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ABSTRACT 
Serotonergic nuclei of the raphe play an important role in psychiatric human 
pathologies as well as in several physiological and homeostatic functions. 
Serotonergic raphe neurons discharge at a characteristically slow and regular 
frequency (1-4 spikes/s) that is generated by mechanisms intrinsic to individual 
cells. Thus, the regular firing of raphe serotonergic neurons maintains the tonic 
output of serotonin (5-HT) at terminal level. The activation of inhibitory 5-HT1A 
(auto)receptors expressed at somatodendritic level by raphe serotonergic cells is 
responsible for the inhibition of their own firing rate (i.e. autoinhibition) and, as a 
consequence, for a decrease of 5-HT release from serotonergic terminals. The 
physiological importance of this auto-inhibitory mechanism has remained 
predictive until it was developed a method to dissect the role of 5-HT1A 
autoreceptors from that of the heteroreceptors.  
The availability of transgenic mice with conditional and tissue-specific knock-
in/out of 5-HT1A receptors is now providing efficient tools to study the 
involvement of 5-HT1A receptor-mediated autoinhibition and the modulatory role 
of serotonin in cognitive or integrative functions, as well as in behavioural states. 
For instance, mice with conditional and selective 5-HT1A receptor overexpression 
in raphe nuclei (Htr1aRO) have been recently developed to study the 5-HT1A 
autoreceptor function and possible disorders associated with increased 
autoinhibition of serotonergic system. Quantitative autoradiographic analysis 
revealed approximately 10-fold Htr1a protein overexpression Htr1aRO mice as 
compared with control littermates. The selective 5-HT1A receptor overexpression 
onto serotonergic neurons of the raphe nuclei in HTr1aRO mice was found to cause 
a severe autonomic dysregulation that often leads to death and shows striking 
similarities with sudden infant death syndrome (SIDS) events in humans.  
The principal objective of the present work was to obtain a more complete 
functional characterization of serotonergic neuron activity in the dorsal raphe of 
HTr1aRO mice, to further study the functional role and the analogies between this 
animal model and SIDS. Serotonergic cells are responsive to changes in pH/CO2 
level in blood and brainstem, thereby sensing and responding to hypercapnia with 
modulatory signals to respiratory nuclei. It has been proposed that one of the 
possible causes of SIDS is a failure in resuscitation in response to 
hypercapnia/hypoxia that follows rebreathing or hypoventilation. Thus, I 
investigated if chemosensitive responses of serotonergic cells where altered in this 
mouse model of SIDS, so to extend the characterization of this animal model of 
human pathology to functional responses that could sensibly be implicated in 
sudden death. 
The research developed on three major intermingled lines, namely: i) assessment 
of distinctive parameters allowing the electrophysiological identification of 
serotonergic neurons when recording with advanced extracellular techniques 
(loose-seal cell-attached patch); ii) comparison of electrophysiological cell 
characteristics, firing pattern(s) and response to 5-HT1A receptor activation of 
serotonergic cells, in 5-HT1ARO compared to wild-type mice; iii) study of 
chemosensitivity of serotonergic cells in wild-type and mutant mice. 
The first step of the present work was to develop a method for 
electrophysiological identification of serotonergic neurons both on whole-cell and 
in loose-seal cell-attached patch-clamp recordings. Thus, I initially developed and 
validated in C57bl/6 mice a robust criterion for discriminating serotonergic 
neurons from non serotonergic cells during recording. This consisted of a 
“visually guided selection” of large neurons located in raphe midline under 
InfraRed microscopy, combined with the presence of an electrophysiological 
criterion, i.e. action potential duration and shape, that was quantified as half-
height width -HHW- in whole-cell and Interval between Upstroke and 
Downstroke –UDI- for action currents in loose-seal cell-attached recordings. 
Thus, serotonergic neurons show a longer action potential/current duration in 
respect to non-serotonergic neurons (1.42 ± 0.40 ms, n=84 and 1.67 ± 0.43 ms, 
n=95, respectively, mean ± SD; P < 0.001, Mann Whitney test). When I applied 
these criteria to identify serotonergic neurons in HTr1aRO and wild type mice I 
discovered that serotonergic neuron of HTr1aRO mice displayed a shorter action 
potential/current compared to serotonergic neurons of wild type mice and a 
smaller cell surface as indicated by cell capacitance. These findings indicate 
subtle, developmental, modifications of morphology and electrophysiological 
properties of HTr1aRO serotonergic cells.  
The next step was to assess if ten times greater expression of 5-HT1A receptor in 
HTr1aROmice produces increased electrophysiological responses 5-HT1A receptor 
activation. For this purpose I measured the inhibition of firing activity of 
serotonergic cells in loose-seal cell-attached recording and the GIRK-related 
conductance activation mediated by 5-HT1A receptors in whole-cell patch-clamp 
experiments. In all tests, I found that dose-response relationships for selective 
agonist (+)8-Hydroxy-N,N-dipropyl-2-aminotetralin (R-8-OH-DPAT) action were 
significantly different, but that the effectiveness of 5-HT1A receptor activation was 
only doubled in HTr1aRO respect to wild type mice. However, HTr1aRO 
serotonergic cells responded to the activation of the 5-HT1A receptors by 
endogenous 5-HT as expected for ten folds overexpression of 5-HT1A receptors. 
Thus, autoinhibition is greatly increased in serotonergic cells of HTr1aRO mice, 
although this is only partially revealed by synthetic agonists, such as R-8-OH-
DPAT.  
Finally, I investigated the chemosensitivity of serotonergic cells in HTr1aRO mice 
and I found that this response, which is physiologically relevant to the respiratory 
alteration found in SIDS victims, is virtually absent in these mice. 
This finding provides a further analogy with human pathology and strengthens the 
notion that the autonomic dysregulation present in HTr1aRO mice could be used 
for elucidating functional mechanisms of SIDS-like autonomic deficits.  
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 INTRODUCTION 
 
In human, non human primates, and other mammals, serotonergic signalling is a 
major modulator of emotional behaviour including fear, anxiety, aggression and 
integrates complex brain functions such as cognition, sensory processing, motor 
activity, and autonomic responses. The diversity between these functions is due to 
the fact that serotonergic system diffusely projects to all brain regions implicated 
in anxiety and related behaviours as well as to autonomic brainstem nuclei where 
it coordinates the activity and the interaction of several other neurotransmitter 
systems. Moreover, serotonin is an important regulator of early brain development 
and adult neuroplasticity, including cell proliferation, migration, differentiation 
and synaptogenesis (Di Pino et al., 2004). As it shapes various brain systems 
during development, it sets the stage for functions that regulate emotions and 
autonomic responses throughout life.  
Indeed, emotional and autonomic dysfunctions in serotonin system appear to be 
settled during development when serotonin plays a role as morphogenetic factor 
(Azmitia, 2001; Whitaker-Azmitia, 2001; Gaspar et al, 2003; Gross et al., 2004; 
Di Pino et al., 2004). Insufficient or excessive levels of serotonin (5-
hydroxytryptamine, 5-HT) during postnatal period (i.e. excessive or poor 
activation of certain serotonin receptors) is believed to produce permanent 
changes in the formation of selected neural connections (Cases et al., 1996; Upton 
et al., 1999; Yan et al., 1997; During and Hornung, 2000). For example, the role 
of 5-HT1A receptors in the maturation of the forebrain seems established. 
Stimulation of 5-HT1A receptors during early postnatal period is necessary for 
normal anxiety-like behaviour throughout life (Gross et al., 2002).  
Furthermore, as serotonin seems to act as true trophic factor, alterations in its 
synthesis, metabolism, and functional turnover may profoundly affect 
morphogenesis of the developing brainstem network.  
The availability of serotonin as “trophic messenger”, as well as neurotransmitter, 
is regulated by synthesizing (L-tryptophan Hydroxylase type 2: TPH2; Gutchneckt 
et al., 2009) and metabolizing (monoamine oxidase A: MAO-A) enzymes, and the 
serotonin transporter (Lesch et al., 2003). The level of serotonin in the synaptic 
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 space at the level of the terminals is regulated by a delicate balance between 
rhythmic firing of serotonergic neurons and the autoinhibitory control exerted by 
serotonin itself on the firing of serotonergic cells through stimulation of their 
somatodendritic 5-HT1A receptors.  
It was predicted that the manipulation of one of these components would affect 
extracellular levels of serotonin at the target regions, thus it would help to 
elucidate the role of serotonin as a morphogenetic factor and as a moderator of 
autonomic functions and emotionality.  
Several studies have shown that serotonergic nuclei play an important role in 
several physiological and homeostatic functions and there is increasing interest in 
the possible involvement of genetic/developmental alterations of the serotonergic 
system in non psychiatric human pathologies.  
In fact, serotonergic neurons make connections with multiple nuclei in the 
brainstem, thereby modulating autonomic functions such as breathing and 
thermogenesis (Richerson, 2004; Hodges et al., 2008). Recently, it has been 
proposed (Paterson et al.,  2006; Duncan et al., 2010) that dysfunction of 
serotonin system may represent the underlying vulnerability in Sudden Infant 
Death Syndrome (SIDS), where rebreathing or hypoventilation result in 
hypercapnia/hypoxia and failure to arouse (Richerson, 1997; Washburn et al., 
2002; Severson et al., 2003; Buchanan et al., 2008; Buchanan and Richerson, 
2009).  
Accordingly, it has been recently shown that selective overexpression of 5-HT1A 
receptors by serotonergic neurons during the early postnatal development of mice, 
produces altered serotonergic autoinhibition and autonomic dysregulation that 
causes life-threatening bradycardic and hypothermic crisis, having striking 
similarities with SIDS (Audero et al., 2008).  
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Functional organization of serotonergic system 
In the central nervous system, the serotonergic system is phylogenetically ancient 
and evolved very early. The basic morphology of serotonergic neurons and their 
anatomical organization is highly conserved from the simplest to the most 
complex of vertebrates, implying that the principal functions of this system in 
physiology and behaviour are also conserved.  
In mammals, virtually all brain serotonergic cell bodies are located in the 
brainstem, especially on or near the midline. As with other brainstem-mediated 
functions, this implies an involvement in basic processes, especially those 
associated with axial functions, such as those controlling the proximal limb and 
trunk muscles, and respiration.  
In vertebrates, the cell bodies of the vast majority of brain serotonergic neurons 
are localized in or near the raphe nuclei (Jacobs and Azmitia, 1992). These 
midline clusters of serotonergic cells constitute ~1/ 1,000,000 of all CNS neurons. 
However, their influence on their target sites appears to go far beyond these 
numbers. In the rat brain it is estimated that there are ~6 x106 serotonergic 
varicosities/mm3 cortical tissue. By extrapolation, this means that each 
serotonergic neuron projecting to the cortex may be responsible for 5 x 105 
serotonergic varicosities, that each of their cortical target neurons receives ~200 
varicosities, and that serotonergic terminals may account for as many as 1/500 of 
all axon terminals in the rat cortex (Audet et al., 1989).  
This makes the serotonergic system the most divergent between monoamine 
neuromodulatory systems. Consistent with the stable distribution of serotonergic 
cell bodies across phylogeny, the projections network also appears to be highly 
conserved. The serotonergic cell fibres enter the various target structures through 
similar pathways and appear to innervate the same target neurons with synaptic 
and non synaptic connections (i.e. volume transmission). Serotonergic cells 
project along several ascending and descending pathways, most of which are 
shared with one or more of the raphe nuclei (Fig. 1). The highest levels of 
serotonergic innervations in the forebrain are seen in limbic areas (temporal lobe, 
hypothalamic and thalamic nuclei, amygdaloid nuclei, and the hippocampus) and 
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 in sensory areas (visual-calcarina, auditory-superior temporal gyrus, 
somatosensory-postcentral cortex, olfactory-amygdaloid nuclei and entorhinal 
cortex, nociceptive-posterior complex). The main targets of the descending 
pathways are the cerebellum, the lower brainstem, and the spinal cord. Lower, but 
clearly detectable serotonin-immunoreactive fibres are found in virtually every 
area of the brain, except in major fibre tracts such as the corpus callosum and 
optic tract.  
Serotonergic neurons also contact non neuronal cells. Serotonergic cells are 
associated with the ependymal cells of the ventricular system through their 
dendrites, with large blood vessels through the cell body, or through processes in 
physical proximity to endothelial cells (Azmitia, 1978). This convergence of 
neuronal and non neuronal input is also conserved and it provides the raphe cells 
with a broad sampling of information from many brain and endocrine systems that 
might have neuronotrophic as well as physiological relevance. 
In the human brain, serotonin neurons are more numerous (>250,000) than in any 
other species and form a tight, small cluster along the midline of the brainstem 
(Tork, 1990). Projections from these clusters are more restricted than the diffuse 
projections seen in rodents. The axons in rats and mice are predominately thin, 
highly branched, and unmyelinated. In primates, highly myelinated fibres are 
common, whereas in rodents they are rare (Azmitia and Gannon, 1983). Thus, the 
organization of the serotonin neurons is more evolved in primates indicating that 
this system, although “ancient”, has evolved during phylogeny and has acquired 
relevant and more specific neuromodulatory influence on lower and higher brain 
functions. 
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Fig.1. Brainstem raphe nuclei localization, projections and their association with 
brain arteries. (A) Schematic drawing showing the location of the serotonergic 
cell body groups in a sagittal section of the rat central nervous system and their 
major projections. OT, olfactory tuberculum; Sept, septum; C. Put, nucleus 
caudate-putamen; G. Pal, globus pallidus; T, thalamus; H, habenula; S. Nigra, 
substantia nigra. B6-B7, dorsal raphe; B8-B9 median raphe; B3, raphe magnus 
and pallidus; B2-B1 raphe obscurus (Consolazione et al., 1982).  
(B) Adult mouse brain in which serotonergic neurons are marked with yellow 
fluorescent protein, dorsal and median raphe nuclei are indicated with arrows, 
asterisk indicate medullary raphe nuclei (Scott et al, 2005). (C)  Brainstem 
serotonergic nuclei association with arteries is showed from the three-
dimensional reconstruction of immunohistochemical labelling of vessels and 
neurons (Severson et al., 2003). 
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Physiology of serotonergic neurons 
Serotonin has been involved in a vast array of physiological and behavioural 
processes in vertebrates, but appears to be essential for none of them (Calas, 1981; 
Jacobs, 1984; Whitaker-Azmitia, 1990). This apparent contradiction could be 
explained by the fact that the expansive system of serotonergic neurons exerts a 
tonic modulatory influence on its widespread targets. This is expressed primarily 
in association with the organism’s motor activity and is in phase with the sleep-
wake-arousal cycle. Like most of neurons in the brain, the activity of serotonergic 
neurons changes significantly across the sleep-wake-arousal cycle and 
serotonergic system is maximally activated during diurnal wake. 
This issue was well examined with extracellular single unit recordings in the 
dorsal raphe nucleus (DRN) of the domestic cat that gives a general insight on 
serotonin neuronal activity (action potential firing) in behaving animals.  
During the quiet waking state, the activity of DRN serotonergic neurons is slow 
and highly regular (Trulson and Jacobs, 1979), just as it is when examined under 
anesthesia and even in vitro (Aghajanian et al., 1968; Mosko and Jacobs, 1976). 
From a firing rate of approximately 3 spikes/s during quiet waking, the activity of 
serotonergic neurons typically increases by approximately 10%-30% in response 
to activating or arousing stimuli. Reciprocally, the activity of these neurons 
declines as the cat becomes drowsy, and becomes even slower upon entering 
slow-wave sleep. Finally the culmination of this state-dependent decrease in 
single unit activity occurs as the cat enters rapid eye movement (REM) sleep, 
when the activity falls virtually silent.  
In general, the pattern of activity across the sleep-wake-arousal cycle in the DRN 
neurons is closely paralleled by serotonergic neurons in other lower groups, the 
only differences are that the latter display higher spontaneous frequency and that 
neuron activity is significantly reduced, but not completely suppressed during 
REM sleep (Fornal and Jacobs, 1988).  
Apart from being switched on or off during the sleep-wake-arousal cycle, 
serotonergic neuron activity is not responsive to sensorial stimuli nor is it changed 
by a variety of physiological variables.  
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 It is assessed that intense or stressful conditions, especially those that evoke 
strong behavioural responses and/or physiological changes of sympathetic 
activation, do not significantly activate serotonergic neuron activity beyond the 
level normally seen during the undisturbed active waking state (Jacobs and 
Fornal, 1992). In further experiments it has been observed there is a relationship 
between a variety of central pattern generator-mediated motor activities such as 
oral-buccal movements and serotonergic activity. Approximately one fourth of 
DRN serotonergic neurons increase activity from two to fivefold before the 
engaging of the repetitive motor behaviour. In contrast, the rest of serotonergic 
neurons maintain a slow and rhythmic activity. 
Contrary to pontine serotonergic nuclei, where few cells respond to central 
pattern-generator behaviours, most of medullary serotonergic neurons are 
activated under at least some of these conditions (Veasey et al., 1995). The degree 
of activation, however, is much less impressive, i.e., 50%-100% above baseline 
versus 100%-400% above baseline for DRN. There also appears to be at least 
some degree of response specificity for these neurons. Thus, virtually all 
medullary serotonergic neurons are activated during treadmill-induced 
locomotion, 50% of them during environmental cooling, but none of these stimuli 
activate serotonergic neurons in DRN. Interestingly, subgroups of neurons in both 
nuclei were found responsive during carbon dioxide hyperpnea (CO2 inhalation). 
These neurons seems to function as central carbon dioxide chemoreceptors, thus 
they have the intrinsic property to sense changes in pH/CO2 in large blood vessels 
and to trigger the proper arousal response as well as stimulation of breathing 
(Nason and Mason, 2006, Richerson, 1995, 1997; Wang et al. 2001; Severson et 
al., 2003, Hodges 2008).  
In summary, the tonic activity of serotonergic neurons, and accordingly the output 
levels of serotonin at the terminals, appear to vary in a stereotypical manner in 
association with motor activity and behavioural states and not specifically in 
association with any processes. The discharge of these neurons appears to reach a 
“ceiling” during active waking beyond which they cannot be activated, regardless 
of the impact of the affecting stimulus on the organism. Therefore, the primary 
role of these neurons in physiology and behaviour may be to coordinate the 
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 activity of target structures (or set the tone for) in conjunction with the organism’s 
level of motor activity and behavioural arousal.  
 
 
Control of serotonergic neuronal activity 
Tonic output of serotonin at the terminal level is maintained by the regular firing 
of raphe serotonergic neurons. The proportionality between the firing rate and 
neurotransmitter release at the terminals was confirmed by in vivo microdialysis 
studies in behaving animals (Auerbach et al., 1989; Kalen et al., 1989; Jacobs and 
Azmitia, 1992). Thus, the unperturbed and highly regular firing activity of raphe 
serotonergic neurons determines a constant release of serotonin from terminals in 
the projection areas.   
Serotonergic raphe neurons discharge at a characteristically slow and regular 
frequency (1-4 spikes/s) that is generated by a mechanism intrinsic to individual 
cells. 
Direct evidence for the pacemaking activity of brain serotonergic neurons was 
presented in a study employing intracellular recordings in vivo. These experiments 
revealed that serotonergic cells displayed a large afterhyperpolarization (AHP), 
followed by a gradual depolarization, and finally a spike (Aghajanian and 
Vandermaelen, 1982). This pattern of repetitive events was also found in 
subsequent intracellular analysis of serotonergic unit activity recorded in brain 
slices containing DRN (Crunelli et al., 1983; Vandermaelen and Aghajanian 1983; 
Allers and Sharp., 2003). When recorded intracellularly, these neurons show very 
high membrane input resistance and a long time constant. Further studies in DRN 
slices led to the following proposed sequence of membrane events generating the 
characteristic slow rhythmic activity (Aghajanian, 1985; Burlhis and Aghajanian, 
1987; Segal, 1985): During an action potential, calcium ions enter serotonergic 
neurons through high-threshold calcium channel. This is followed by a large (15-
20 mV) AHP generated by a calcium-activated potassium conductance. This AHP 
results in a long relative refractory period, thus preventing action potential 
discharge in bursts and ensuring slow rates of firing. As the AHP decreases (due 
to sequestration and/or extrusion of calcium), the relative depolarization 
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 deinactivates a low-threshold calcium current and an early transient outward 
potassium current (IA). The currents generated by the activation of these two 
voltage-dependent channels are opposed, with IA tending to slow the rate of 
depolarization and the low-threshold calcium conductance increasing it. Under 
normal conditions, the calcium conductance is stronger, thus leading to a shallow 
ramp depolarization, which ultimately reaches threshold, guarantees an action 
potential, and, as the calcium enters the cell, re-initiates the sequence of events. 
The slope of this ramp is what determines the rate of discharge of serotonergic 
neurons. This sequence of events is similar to that seen in other pacemaker cells 
studied in both vertebrate and invertebrate preparations (Llinas, 1988). It should 
be noted, however, that this classical representation of ion channel activation 
underlying  pacemaker activity is rather simplistic and does not take into 
consideration the possible contribution from other voltage-activated channels 
specific to serotonergic cells (Penington and Fox, 1995, Bayliss et al. 1997). 
In addition to such intrinsic ionic mechanisms, it appears established that the 
noradrenergic system exerts a tonic facilitatory modulation of this intrinsic 
activity during wake and that the GABAergic system is tonically inhibitory on 
serotonergic cells during sleep (see in Adell, 2002). Glutamatergic input from 
cortical areas in response to phasic sensory input can transiently increase 
serotonergic neuron firing, but a blockade of glutamate receptors does not 
appreciably affect constant discharge of serotonergic cells. 
Noradrenergic input is believed to drive changes in serotonergic activity across 
the sleep-waking cycle, since both neuronal groups are wake-on and REM-off. 
During waking state, noradrenergic input to raphe nuclei produces a tonic and 
maximal activation of serotonergic neurons (Baraban and Aghajanian, 1980; 
Adell., 2002; Haddjeri et al., 2004). In fact, an iontophoretic application of an α1-
adrenergic agonist (phenylephrine) or noradrenaline does not alter spontaneous 
activity of serotonergic cells during wake. In contrast, GABAergic system seem to 
be involved in an inhibition of serotonergic activity during sleep, as an 
iontophoretic application of the GABA antagonist bicuculline during sleep 
restores activity of the DRN serotonergic neurons to near the waking level. 
However, the same antagonist applied during waking state does not change 
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 serotonin neuron activity (Levine and Jacobs, 1992). These results indicate that a 
GABAergic input to brain serotonergic neurons becomes activated during sleep 
and exerts a powerful inhibitory influence exclusively during that state. 
In conclusion, apart from being switched off or on by two opposing systems 
during the sleep-wake cycle, it seems that regular firing of serotonergic neurons is 
not perturbed significantly by any afferent neurotransmitter system. Instead, there 
is a local mechanism that appreciably regulates the firing of serotonergic neurons 
during wake and allows for transient changes in firing activity that can be 
observed during specific behaviours. 
This is a tonic inhibition of serotonergic neuron activity, exerted by serotonin 
itself through activation of 5-HT1A (auto) receptors, expressed on the soma of 
serotonergic neurons. This feedback control is called autoinhibition and is the 
most important mechanism that modulates the serotonergic firing rate in raphe 
nuclei and the consequent release of serotonin at terminals.  
Autoinhibiton is therefore crucial for serotonergic system functioning and 
dysregulation of this fundamental physiological mechanism is suspected to be 
involved in several pathological states from anxiety to aggression (Audero et al., 
2007), vulnerability to stress, and depression (Richardson-Jones et al., 2010) and 
SIDS (Audero et al., 2008). 
 
A SUMMARY REVIEW of synthesis, release, receptor actions and re-uptake of 
serotonin can be found at the end of the Introduction section 
 
 
5-HT1A autoreceptors and heteroreceptors  
Dorsal raphe nucleus together with hippocampal formation are the brain areas 
most enriched with 5-HT1A receptors (Chalmers et al., 1991; Kia et al. 1996; 
Miquel et al., 1991; Pompeiano 1992).  
In the dorsal raphe, 5-HT1A receptors are expressed mainly by serotonergic 
neurons and distributed in their plasma membrane of perikarya and dendrites (Kia 
et al. 1996; Riad, 2000).  
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 This localization is also typical of some forebrain areas such as the septum or the 
cortex, whereas in the hippocampal formation, 5-HT1A receptors appear to 
predominate on the dendritic spines (Kia et al. 1996). It is therefore clear that 
5-HT1A receptors have a role of autoreceptors in dorsal raphe and a role as 
heteroreceptors in forebrain areas. Both receptor populations are coupled to Gi/o 
proteins, and their activation results in membrane hyperpolarization and decreased 
neuronal excitability. Thus 5-HT1A receptors in raphe serotonergic neurons 
mediate the mechanism of autoinhibition whereas in the forebrain region they 
inhibit the activity of the target neurons.  
Regional differences in Gα subunit coupling and downstream effectors of 5-HT1A 
receptors have been demonstrated.  
In dorsal raphe, 5-HT1A receptors seem mainly coupled to Gαi3, whereas in the 
hippocampus they are coupled to Gαo, and in the frontal cortex to Gαo and Gαi3 
G protein subunits. In addition, heteroreceptors seem to inhibit adenylate cyclase, 
while no coupling with this enzyme has been demonstrated in raphe neurons 
(Hensler, 2003; Lanfumey and Hamon 2004). 
Although there is clear difference in their functional activity and associated 
transducing systems, all 5-HT1A receptors have very similar pharmacological 
profiles. Therefore, it has been difficult to infer which receptor population is 
responsible for the effects of agonists administration in vivo. 
In the rat, administration of R-8-OH-DPAT and other 5-HT1A receptor agonists 
causes a wide range of behavioural and physiological effects including the 
induction of the serotonergic behavioural response, hyperphagia, hypothermia, 
decrease in heart rate, altered sexual behaviour, and nociceptive response (Green 
and Grahame-Smith, 1976; Green and Heal, 1985; Glennon and Lucki, 1988; 
Millan et al., 1991; Lucki, 1992). In addition, there is a large amount of literature 
on basic and clinical data attesting to the anxiolytic and antidepressant activity of 
5-HT1A receptor agonists.  
In rats, intra-raphe injection of 5-HT1A receptor agonists evokes hypothermia 
(Higgins et al., 1988; Hillegaart, 1991), however inhibition of 5-HT synthesis and 
serotonin system lesions do not prevent hypothermia when the agonists are 
injected systemically (Bill et al., 1991; O’Connell et al., 1992; Millan et al., 
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 1993). In comparison, in the mouse, lesions of the serotonergic system abolish the 
hypothermic response to 5-HT1A receptor agonists (Goodwin et al., 1985; Bill et 
al., 1991).  
Therefore, it appears that differences exist across species in the mechanism(s) 
underlying the hypothermic effect of 5-HT1A receptor agonists; in the mouse it 
appears that this effect is due to inhibition of serotonergic neuron firing by 
activation of somatodendritic receptors (i.e presynaptic), whereas in the rat the 
hypothermic effect seems to be mediated via both pre- and postsynaptic 
mechanisms (presumably involving different neural circuits).  
Studies of the mechanisms underlying the anxiolytic properties of 5-HT1A 
receptor agonists were in favour of presynaptic action, at least in some models, 
although an involvement of postsynaptic mechanisms could not be ruled out 
(Handley, 1995; DeVry, 1995; Jolas et al., 1995).  
Even if a considerable amount of information on the roles of the 5-HT1A receptor 
populations has been gathered, our present knowledge on the multiple roles of 5-
HT1A receptor-mediated regulation of mood and autonomic function(s) is elusive 
and warrants the development of new strategies to dissect the effects of their 
function in vivo.  
The generation of transgenic mice has greatly expanded the possibility to obtain 
new information on this issue. It is well known that 5-HT1A receptors are involved 
in anxiety-related behaviour, as 5-HT1A receptor knock-out mice display anxiety-
like end-phenotype in response to novel cues (Gross et al., 2004; Olivier et al., 
2001). However only with the development of conditional knock out/in it was 
possible to establish a clear participations of one 5-HT1A receptor population in 
the regulation of emotions and their disorders. Hippocampal specific and 
conditional 5-HT1A receptor-rescue mice were used to show that the control of 
forebrain activity by postsynaptic 5-HT1A receptors, during early postnatal period, 
is necessary to establish normal anxiety-like behaviour in the adult, while raphe 5-
HT1A receptors are not involved in this process (Gross et al., 2002).  
In contrast, 5-HT1A receptors in raphe nuclei have a wider range of functions as 
they control serotonin neuron activity and therefore serotonin release from 
terminals onto almost all brain regions.  
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 Indeed, the level of expression of 5-HT1A receptors in raphe nuclei has been 
correlated to a panel of pathological manifestations in mice. Thus, selective 
overexpression of 5-HT1A receptors in raphe nuclei changes the level of 
autoinhibition and leads to an aggressive endophenotype accompanied by 
profound dysregulation of autonomic system (Audero et al., 2008), whereas 
selective decrease in the expression of these receptors produces vulnerability to 
stress and loss of response to antidepressant drugs (Richardson-Jones et al., 2010). 
 
 
The 5-HT1A receptor and autoinhibition 
The intrinsic negative feedback mediated by 5-HT1A receptors is the major 
mechanism that controls the activity of brain serotonergic neurons. Thus, as the 
levels of brain serotonin increases, e.g. following administration of its precursors, 
L-tryptophan or L-5-hydroxytryptophan, the activity of brain serotonergic neurons 
correspondingly decreases (Aghajanian, 1972; Trulston, 1975). It is presumed that 
this neuronal decrease is a homeostatic response that acts to compensate for 
increases in synaptic levels of serotonin.  
Converging experimental evidence showed that the nature of this feedback is a 
short local loop, rather than a long loop, involving the response of postsynaptic 
target neurons. Studies with iontophoresis demonstrated that serotonergic neurons 
are directly responsive to the application of serotonin and that drugs which release 
serotonin from endogenous stores, or block its reuptake, depress serotonergic unit 
activity in the DRN, independent of any feedback from the forebrain (Aghajanian, 
1972; Mosko et al., 1977). These neurophysiological findings were coupled with 
anatomic evidence that serotonergic neurons make dendrodendritic and 
dendrosomatic connections, with serotonergic neurons in the same, as well as in 
other, raphe nuclei (Mosko et al., 1977; Kapadia et al., 1985; Wiklund et al., 
1981).  Increased levels of synaptic serotonin appear to inhibit serotonergic 
neurons by a direct action at somatodendritic serotonin receptors (the 5-HT1A 
autoreceptors). Thus serotonin 5-HT1A receptor agonist drugs such as 8-OH-
DPAT strongly inhibit neuronal firing.  
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 8-OH-DPAT is highly potent and selective at 5-HT1A site, it displays high affinity 
(Ki=~2nM) and selectivity (>400-fold) relative to other 5-HT binding sites 
(5-HT1B,1C,1D,5-HT2, or 5-HT3) (Van Wijngaarden et al., 1990). In intracellular 
studies 8-OH-DPAT mimicked the hyperpolarizing action of serotonin on 
serotonergic neurons at concentrations approximately 1000 time lower than that of 
serotonin (Williams et al., 1988). This compound inhibits the serotonergic firing 
rate also in vivo in dose-dependent manner (Fornal et al., 1994a). The onset of 8-
OH-DPAT action is rapid (20 s) and the complete suppression of neuronal activity 
is observed at low doses (5-20 ug/kg). The inhibitory action of 8-OH-DPAT is 
blocked by several non-selective antagonists, including spiperone (Lum and 
Piercey, 1988; Blier et al., 1989, 1993a; Escandon, 1994) and (-)-tertatolol (Jacobs 
et al., 1992; Jolas et al. 1993; Lejeune et al., 1993; Prisco et al., 1993), and by 
more selective 5-HT1A receptor antagonists as WAY100635 (Fletcher et al. 1995; 
Corradetti et al., 1996; Fornal et al., 1996).  
5-HT1A receptor activation inhibits neuronal firing mediating the 
hyperpolarization of cell membrane by increasing membrane conductance to 
potassium and decreasing calcium conductance (Williams et al., 1988). The 
activation of 5-HT1A receptors leads to the dissociation of Go/Gi-protein, the βγ 
subunit activates an inwardly rectifying potassium conductance (GIRK), and the α 
subunit inhibits the adenylate cyclase. The G protein is directly responsible also 
for inhibition of N-type Ca++ channels and Ica.Raphe channels (perhaps a P/Q type 
channels) for slowing the activation of both currents to a similar extent (Penington 
and Fox, 1995, Bayliss et al., 1997). Together, these two mechanisms may 
provide a feedback inhibition of raphe neuronal activity and thus limit the 
serotonergic tone imposed on neurons in target areas. According to this scheme 1) 
activation of inwardly rectifying K/ channels by serotonin would inhibit the firing 
of raphe neurons, thereby decreasing activity-dependent serotonin release, and 2) 
inhibition of calcium current by serotonin, if present at serotonergic terminals, 
would directly decrease calcium-dependent transmitter release (Bayliss et al., 
1997).  
Apparently, this feedback exerts a tonic influence on serotonergic activity since 
administration of 5-HT1A receptor antagonists increases the firing rate, and 
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 regularizes the discharge pattern, of serotonergic neurons in behaving animals 
(Fornal et al., 1988, 1989). Furthermore, as expected of a negative feedback 
system, the autoreceptor-mediated mechanism appears to be engaged when 
neurons are firing at a relatively high firing rate and disengaged at lower firing 
rates. Thus, under conditions where serotonergic neurons are known to be 
relatively inactive, e.g. during sleep, autoreceptor blockade has little or no effect 
on neuronal activity. However, under conditions where serotonergic neurons are 
activated and serotonin release would be expected to exert feedback inhibition, 
e.g. during arousal, autoreceptor blockade is manifested as a significantly larger 
increase in the activity of serotonergic neurons (Fornal et al., 1988, 1989; Jacobs 
and Fornal., 1997). These results provide evidence for the physiological 
significance of this feedback inhibition.  
Indirect evidence also suggests that the density of cell body autoreceptors on 
individual serotonergic neurons may be a factor in determining both their level of 
spontaneous activity as the degree to which they respond to 5-HT1A receptor 
agonists (Heym et al., 1982; Jacobs et al., 1983). Thus neurons with few 
autoreceptors would be firing with faster rate, due to less feedback inhibition, and 
less responsive to 5-HT1A receptor agonists, due to fewer sites for drug-receptor 
interactions. Neighbouring serotonergic neurons in the DRN can exhibit a variety 
of interactions such synchronization of activity, inhibition, or mutual inhibition of 
each other (Wang et al., 1982). These data are consistent with the aforementioned 
concept that serotonergic neurons influence the activity of other serotonergic 
neurons.  
In summary, several studies provide the evidence that serotonin autoreceptor are 
activated under normal conditions by endogenous serotonin release, and that the 
level of autoinhibition varies as a function of basal firing rate and behavioural 
state of the animal.  
One physiological role of these receptors is therefore to function as sensors which 
regulate serotonin neuron that respond firing according to extracellular serotonin 
level in raphe thereby setting the steady-state concentration of serotonin released 
at terminal synapses.  
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 Alterations in normal autoreceptor function may lead to pronounced changes in 
central serotonin neurotransmission and may play a role in the etiology of various 
autonomous and affective disorders (e.g., SIDS, anxiety, aggression) in which 
serotonin has been implicated. 
 
 
A mouse with a selective overexpression of 5-HT1A receptor on serotonergic 
raphe neurons as a model of the functional study of increased autoinhibition 
and its consequence in vivo: the sudden infant death syndrome (SIDS). 
As already mentioned, the 5-HT1A autoreceptor is responsible for the mechanism 
that regulates the firing rate of serotonergic neurons and thus thereby release of 
serotonin at terminals (i.e. autoinhibition).  
The physiological importance of this regulating mechanism has remained 
predictive until it was developed a method to dissect the role of 5-HT1A 
autoreceptor from that of the heteroreceptors. Transgenic mice with conditional 
and tissue-specific knock-in/out of 5-HT1A receptors are an efficient tool to study 
5-HT1A receptor-mediated autoinhibition and the modulatory activity of serotonin 
at postsynaptic sites, then their role in cognitive or integrative functions, as well 
as behavioural states. 
Mice with conditional and selective 5-HT1A receptor overexpression in raphe 
nuclei (Htr1aRO) were developed recently (Audero et al., 2008) and they has been 
used as powerful tool to study autoreceptor function and the possible disorders 
associated to excessive autoinhibition. These mice showed 5-HT1A receptor 
protein overexpression in raphe nuclei of the mid- and hindbrain. Quantitative 
autoradiographic analysis reveals approximately 10-fold more receptor protein in 
Htr1aRO mice as compared with control littermates. 
Unexpectedly, while mice completely lacking serotonin (Richer et al., 2002) or 
serotonin neurons (Taylor et al., 2005; Urbain et al., 2006) are viable, these mice 
exhibited autonomic crises that occurred during a limited developmental period 
and frequently progressed to death. While baseline heart rate and body 
temperature were normal, consistent with robust homeostatic control of autonomic 
activity, the altered serotonin neurotransmission led to sporadic crises 
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 characterized by decreases in heart rate and body temperature that persisted for 
several hours and frequently recovered only after several days. In 37% of the 
observed crises severe bradycardia and hypothermia were irreversible and 
progressed to death. Death was most frequent between PND25 and PND80, and 
only approximately 30% of Htr1aRO mice survived beyond PND120. Death could 
be prevented by treating Htr1aRO animals continuously with doxycycline which 
suppresses 5-HT1A receptor overexpression in raphe, or by delivering 
WAY100635 with osmotic minipumps. Furthermore, overexpression of 5-HT1A 
receptor beginning at PND60 led to significantly fewer deaths than 
overexpression beginning at PND40 confirming the existence of a sensitive 
developmental period for the death phenotype. 
Autonomic crises in Htr1aRO animals appear to share critical features with sudden 
infant death syndrome (SIDS). SIDS is a condition characterized by the 
unexplained death of an otherwise healthy infant aged between a month and a 
year. Typically, the infant is found dead in the early morning after a sleep period.  
A rapidly growing number of studies indicates that genetic, developmental, or 
functional alterations of the serotonergic system may contribute to SIDS (Okado 
et al., 2002; Sawaguchi et al., 2003; Paterson et al., 2007; Rand et al., 2007; 
Hodges et al., 2008; Morley et al., 2008; Thach, 2008). SIDS victims have been 
found to have abnormalities in the brainstem serotonergic system (Paterson et al., 
2007; Duncan et al., 2010) including an increase in the number of serotonergic 
neurons in the medulla with immature and granular cell morphology, which 
suggests a failure or delay in the maturation of these neurons in SIDS infants.  
It has been proposed that the mechanisms leading to SIDS represent a failure in 
the neural integration of the cardiovascular and respiratory systems, with a 
concomitant failure to arouse from sleep (Harper et al., 2000; Horne et al., 2004).  
The involvement of a defect of serotonin system in SIDS would not be surprising 
given the modulatory actions of serotonin on many physiological functions (e.g. 
arousal, sleep, cardiorespiratory, and thermoregulatory functions) that resulted 
anomalous or impaired in newborns that succumbed to SIDS. 
Although it appears that SIDS infants do not exhibit increased Htr1a autoreceptor 
expression, it is possible that they have functionally equivalent deficits in 
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 serotonin homeostasis that include alterations in local serotonin release, changes 
in intrinsic electrophysiological and chemosensitive properties of serotonin 
neurons, and deficiencies in autoregulatory feedback networks, such as those 
involving noradrenaline (Haddjeri et al., 2004) or γ-aminobutyrric acid (GABA) 
(Celada et al., 2001). 
The triple-risk model of SIDS (Filiano et al., 1994) argues for the simultaneous 
occurrence of an intrinsic susceptibility, an exogenous stressor, and a critical 
developmental time period. Studies on Htr1aRO animals showed that altered 
serotonin homeostasis alone is sufficient to precipitate catastrophic autonomic 
failure and death in the absence of overt stressors. 
Indeed, it was proposed that serotonergic system dysfunction would be 
responsible for apnea and death in SIDS, because chemosensitive serotonergic 
neurons would fail to activate the arousal response and to induce dyspnea 
following PCO2  increase during sleep (Buchanan and Richerson, 2009). 
 
 
The present study on Htr1aRO mice has takes advantage of the availability of mice 
with altered expression of 5-HT1A receptors to extend our knowledge on cellular 
mechanisms of 5-HT1A receptor-mediated autoinhibition and to investigate the 
possible altered sensitivity to CO2/pH in this animal model of SIDS. 
 
 
SUMMARY REVIEW  
 
 
Synthesis, storage, and release of serotonin. 
The initial step in the synthesis of serotonin is the facilitated transport of the 
amino acid L-tryptophan from blood into brain (Fig. 2). L-tryptophan is an 
essential aminoacid assumed with diet proteins and competes with other neutral 
large amino acid to enter the cytoplasm. In the serotonergic neuron L-tryptophan 
is converted to 5-hydroxytryptophan (
Serotonin synthesis  
5-HTP) by the rate limiting enzyme L-
18
 tryptophan hydroxylase type II (TpH 2), the brain isoform. This enzyme is 
synthesized only in serotonergic cell bodies of the raphe nuclei and its distribution 
in brain is similar to that of serotonin itself. The enzyme requires both molecular 
oxygen and a reduced pteridine cofactor, such as l-erythro-tetrahydrobiopterin 
(BH4), for activity. In the enzymatic reaction, one atom of oxygen is used to form 
5-HTP and the other is reduced to water. The pteridine cofactor donates electrons, 
and the unstable quinonoid dihydrobiopterin that results is regenerated 
immediately to the tetrahydrobiopterin form by a NADPH-linked enzymatic 
reaction:  
L-tryptophan +BH4+O2→L-5-HTP+quinonoid BH4 +H2O 
The affinity of partially purified L-tryptophan hydroxylase for L-tryptophan is 
extremely low, approximately a Km of 30 to 60 μM (Friedman et al., 1972), a 
concentration comparable to that of L-tryptophan in brain. If the concentration of 
L-tryptophan in serotonergic neurons is assumed to be comparable to that in 
whole brain, the enzyme would not be saturated with substrate and the formation 
of serotonin in brain would be expected to rise as the brain concentration of L-
tryptophan increases. Conversely L-tryptophan depletion in vivo leads to a large 
drop in extracellular levels of serotonin and metabolites in the dorsal raphe 
nucleus (Bel and Artigas, 1996).  
Relevant to studies in slices is the fact that in vitro L-tryptophan bioavailability is 
lower, due to the impossibility for cells to synthesize or derive this aminoacid. In 
vitro preparations lacking L-tryptophan also have low concentration of serotonin 
that is rapidly depleted, partly during cutting/maintenance of brainstem slices and 
partly by pharmacological activation of serotonergic neurons (Mlinar et al., 2005). 
Supplementation of L-tryptophan to in vitro  preparations was found the only way 
to restore the serotonin turnover and the regulatory mechanisms of firing rate 
observed in vivo (Liu et al. 2005, Mlinar et al., 2005; Evans et al. 2008).  
The other enzyme involved in the synthesis of serotonin, the aromatic L-amino 
acid decarboxylase (AADC), is a soluble pyridoxal-5′-phosphate-dependent 
enzyme which converts 5-HTP to serotonin. Even this enzyme has a Km of 10 
µM, much higher than the concentration of substrate 5-HTP and contrary to 
TpH2, it is contained also in catecholaminergic neurons. 
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Neosynthesized serotonin is stored in vesicles through its active transport from the 
cytoplasm. The Vesicular Mono-Amine Transporter type 2 (VMAT-2) uses the 
electrochemical gradient generated by a vesicular H+-ATPase to drive transport, 
such that a cytoplasmic amine is exchanged for a luminal proton; that is, uptake of 
serotonin is coupled to efflux of H+ (Erickson et al., 1992). Vesicles storing 
serotonin contain a specific protein that binds serotonin with high affinity and 
virtually no ATP is present. This protein binds serotonin with high affinity in the 
presence of Fe2+ and is secreted along with serotonin by a calcium-dependent 
process. 
Serotonin storage 
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Fig.2. The biosynthesis and catabolism of serotonin.  
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 The release of serotonin in raphe nuclei originates from somatodendritic area, and 
presumably from the recurrent axon collaterals, in the efferent projections from 
axon terminals. The nature and regulation of serotonin release from these sites 
may be different. 
Serotonin release  
There is considerable evidence that the release of serotonin occurs by exocytosis 
at axon terminals and axon collaterals, that is, by the discharge from the cell of the 
entire contents of individual storage vesicles. More discussed is the nature of 
serotonin release in the somatodendritic area. The dendrites of serotonergic cells 
have spines and are poorly branched, and generally remain within the neuropil of 
raphe nuclei (Adell et al., 1993, 2002). These dendrites synthesize serotonin, but 
those which contain vesicles are scarcer and their presence in the DR of the rat is 
equivocal (Chazal et al., 1987; Descarries et al., 1986). Moreover, studies in 
which extracellular concentration in the DRN was directly measured with 
microdialysis in vivo gave contradictory results on the nature of release.  
Thus, following these findings, it was suggested a different mode of storage 
and/or release of serotonin in these dendrites also exist, primary from 
cytoplasmatic pool and independent from neuron firing (Adell, 2002; Harsing, 
2006; De kock et al., 2006). 
The rate of serotonin release at axon terminals is dependent on the firing rate of 
serotonergic soma in the raphe nuclei. Numerous studies have revealed that an 
increase in raphe cell firing enhances the release of serotonin in terminal fields. 
The opposite effect is observed when raphe cell firing decreases (Bosker et al., 
1994; Kalen et al. 1989). This means that a mechanism that changes the firing rate 
of serotonergic neurons modifies the release of serotonin as well. An important 
mediator of such mechanism is the somatodendritic autoreceptor 5-HT1A, which, 
as discussed elsewhere, is the receptor subtype that is responsible of 
autoinhibition. 
 
Serotonin (5-HT) acts at the projection area through at least 14 subtypes of 
receptors that are divided into seven major classes, all are G-protein coupled 
Serotonin receptors 
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 receptors except 5-HT3 that is ionotropic. For a detailed review of serotonin 
receptor subtypes and their functional roles see Barnes and Sharp (1999). 
The subtype 5-HT1A is responsible for some of the best known postsynaptic 
inhibitory actions of 5-HT, especially in the hippocampus and cortex. 5-HT1A 
receptors on serotonergic cell bodies mediate tonic autoinhibition of their action 
potential discharge. 
5-HT1B/5-HT1D receptors (5-HT1D, in humans) act as autoreceptors at axon 
terminals in rats and primates and their activation inhibits serotonin release from 
axon terminals. These receptors can also act as presynaptic heteroreceptors and 
inhibit the release of other neurotransmitters (e.g. glutamate). 
5-HT2A,C receptors are expressed postsynaptically and are associated with the fine 
serotonergic fibers in the middle layers of the cortex. They are responsible for 
many of the behavioural effects of serotonin and have been shown to be involved 
in the action of major hallucinogenic drugs.  
5-HT4 5-HT6 and 5HT7 are coupled to Gs proteins, and activate cAMP at 
postsynaptic level. All these receptors are suspected to be involved in synaptic 
plasticity.  
5-HT5 receptors are highly expressed in hippocampus, but their transduction 
mechanisms and functional role remain elusive. 
Finally, 5-HT3 is the only ionotropic serotonin receptor. Opening of the channel 
produces a cationic current that depolarizes the neurons. This receptor is found in 
limbic areas, where it may serve a role in anxiety and psychosis; in the substantia 
gelatinosa, where it may modulate sensory input; and in the area postrema, where 
it may stimulate emesis.  
This large variety of serotonin receptors may account for the multifarious action 
of serotonin and may explain how serotonergic neurons, that show a rather simple 
pattern of firing and communicate through unmyelinated fibres impinging onto 
non specialized postsynaptic sites, could activate specific responses in 
neighbouring cells. In fact, different neurons would manage to decipher the 
“uniform” serotonin message into specific physiological responses through the 
expression of different panels of receptors. 
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 The principal mechanism that terminates the actions of serotonin on postsynaptic 
sites is the re-uptake of the neurotransmitter by the serotonin transporter (SERT) 
located in the plasmamembrane of serotonergic neurons. Activity of 
Termination of serotonin action. 
SERT 
regulates the concentration of serotonin in the synapse, thereby influencing 
synaptic transmission. The uptake system for serotonin is saturable and of high 
affinity, with a Km value for serotonin of approximately 0.2 to 0.5 μM. Uptake of 
serotonin is an active process that is temperature-dependent and has a requirement 
for external Na+ and Cl−; it is inhibited by metabolic inhibitors as well as by 
inhibitors of Na/K ATPase activity. From these and other data, it has been inferred 
that the energy requirement for serotonin uptake is not used directly to transport 
serotonin but, rather, is necessary to maintain the gradient of Na+ across the 
plasma membrane, upon which serotonin uptake is dependent. The current model 
of transport has one Na+, one Cl− and one protonated serotonin binding to the 
transporter extracellularly prior to translocation to form a quaternary complex that 
subsequently undergoes a conformational change to release the neurotransmitter 
and the ions into the cytoplasm. The conformational change may involve the 
“opening” of a pore formed by some portion of the transmembrane domains of the 
SERT. In the cytoplasm, K+ associates with the SERT to promote reorientation of 
the unloaded carrier for another transport cycle. In addition to facilitating the 
removal of transmitters from the synapse, plasma membrane transporters function 
under certain circumstances to release transmitter by a non-Ca2+-dependent, that 
is, non-exocytotic, process. The role of such transporter-mediated release in 
physiological circumstances is speculative (Sitte et al., 2000, 2001). However, 
certain drugs elicit the release of serotonin, at least in part, through such a 
mechanism. For example, both fenfluramine and MDMA act as substrates for the 
SERT and not only inhibit the transport of serotonin into the cell but also facilitate 
its outward transport. The release of serotonin caused by drugs such as 
fenfluramine is prevented by inhibitors of the SERT (Hilber et al., 2005). 
Once transported inside the cell, serotonin is substrate of the enzyme monoamino 
oxidase that catalyzed the first path of serotonin catabolism. Monoamino oxidase 
(MAO) converts serotonin to 5-hydroxyindoleacetaldehyde, and this product is 
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 oxidized by an NAD+-dependent aldehyde dehydrogenase to form 5-
hydroxyindoleacetic acid (5-HIAA). The intermediate acetaldehyde also can be 
reduced by an NADH-dependent aldehyde reductase to form the alcohol 5-
hydroxytryptophol. Whether oxidation or reduction takes place depends on the 
ratio of NAD+ to NADH in the tissue. In brain, 5-HIAA is the primary metabolite 
of serotonin.  
There are at least two isoenzymes of MAO, referred to as MAO-A and MAO-B. 
These isoenzymes are integral flavoproteins of outer mitochondrial membranes in 
neurons, glia and other cells. Evidence for the existence of isoenzymes was based 
initially on differing substrate specificities and sensitivities to inhibitors of MAO. 
For example, both serotonin and noradrenaline are metabolized preferentially by 
MAO-A. Selective inhibitors of each form of MAO exist: clorgyline or 
moclobemide for type A and deprenyl for type B.  
Serotonergic cell bodies contain predominantly MAO-B, for which serotonin is 
not a preferred substrate. The low level of MAO-A in serotonergic neurons 
suggests that glial cells might have an important role in degrading the 
neurotransmitter serotonin. Indeed, inhibitors of MAO-A but not MAO-B have 
been shown to increase brain content of serotonin and to have antidepressant 
activity. Thus, serotonin may well be oxidized preferentially by MAO-A in vivo, 
as it is in vitro, even though serotonergic neurons do not contain much of this 
form of the enzyme. The principal role of MAO-B in serotonergic neurons might 
be to eliminate foreign amines and minimize their access to synaptic vesicles. In 
conjunction with membrane and vesicle 5-HT uptake systems, this could 
contribute to the purity of serotonin delivered to the synaptic cleft. 
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 AIM 
 
The selective overexpression of 5-HT1A receptors on serotonergic neurons of the 
raphe nuclei in transgenic mice was found to cause severe autonomic 
dysregulation that often lead to death. This is the unique lethal phenotype and 
involves one protein modification in the serotonergic system. 
The main aim of the present work was to study the modification in 
electrophysiological properties and responses of serotonergic neurons caused by 
the selective 5-HT1A receptor overexpression in the dorsal raphe nuclei.  
In particular, we were interested in characterizing the modifications in functional 
responses to 5-HT1A receptor activation and in the main autoregulatory 
mechanism mediated by this receptor (autoinhibition). 
In addition, the pathological profile caused by serotonergic cells 5-HT1A receptors 
overexpression shares feature in common with SIDS events. 
Therefore we studied the possible modifications induced by 5-HT1A receptors 
overexpression on serotonergic neuron properties as chemosensitivity, that is 
suspected to be involved in physiological alterations leading to SIDS and that 
could contribute to produce SIDS-like events in Htr1aRO mice. 
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 EXPERIMENTAL PROCEDURES 
All animal procedures were conducted according to the European Community 
Guidelines for Animal Care (DL 116/92, application of the European 
Communities Council Directive 86/609/EEC) and approved by the Committee for 
Animal Care and Experimental Use of the University of Florence. 
Mice C57bl/6, were purchased from Harlan (Harlan Italy s.r.l., Milano). Both 
male and female offspring with mother were received when aged 17 days 
postnatal (postnatal day – PND 17) and were used for whole-cell experiments at 
PND 21-28 and for loose-seal cell-attached experiments when adult.  
Animals 
Mice with conditional over-expression of 5-HT1A receptor in serotonin neurons of 
the raphe nuclei (Htr1a Raphe Overexpressing - Htr1aRO) were developed and kindly 
provided by Dr. Enrica Audero and Dr. Cornelius Gross,  EMBL, Monterotondo.  
These transgenic mice were produced by driving expression of 5-HT1A receptor 
under the control of the serotonin transporter gene (5-HTT, SERT or Slc6a4) 
promoter using the tetracycline-off (tet-OFF) system (Fig. 3) (Kistner et al., 1996; 
Gross et al., 2002). Further details for their production have been published and 
are summarized in Box 1.  
 
Transgenic mice with reversible overexpression of 5-HT1A receptor in serotonin 
neurons showed doxycycline-reversible overexpression of 5-HT1A receptor 
Fig.3. Schematic representation of the genetic 
construct used to obtain Htr1aRO mice. Mice in 
which tTA-binding sites (7x tetO) and a 
minimal cytomegalovirus promoter were 
engineered into the 5' untranslated region of 
Htr1a (Htr1atetO) were crossed with mice in 
which the tTA coding sequence was inserted at 
the start codon of the serotonin transporter 
(Slc6a4tTA).  
In situ hybridization and ligand 
autoradiography confirmed the Slc6a4tTA allele 
to be a null allele of the serotonin transporter 
(from Audero et al., 2008). 
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 protein exclusively in raphe nuclei, as shown by ([125I]p-MPPI autoradiography, 
when compared with littermate control mice (Fig. 4). When necessary, 
experiments were carried out on Htr1aRO mice treated with doxycycline (which 
suppress Htr1A receptor OverExpression) to assure that the results observed are 
not caused by deficiency of 5-HTT function.  
Transgenic mice were coded with ear tags at postnatal day 18-20 and genotyped 
(see infra for details) and separated from mothers at PND21. 
 
Mice were group housed (3-5/cage), Htr1aRO and wild type together, on a 12:12 
light/dark cycle (lights off at 7:00 p.m.) in a temperature-controlled environment 
(21°C). Food and water were provided ad libitum. When required, doxycycline 
was given to the animals or pregnant mothers in the form of food pellets (40 
mg/kg food).  
 
 
 
Fig. 4. Htr1aRO mice have 
selective and reversible 
overexpression of Htr1a 
in serotonin neurons. 
(A) Htr1aRO mice show 
doxycycline -sensitive 
overexpression of Htr1A  
protein exclusively in 
raphe nuclei, as shown 
by 125I-MPPI–4-(2’-
Methoxy phenyl)-1-[2’-(n-
2’’ pyridinyl)-[125I]-iodo 
benzamido] ethyl 
piperazine)autoradiograp
hy, when compared with 
littermate control mice  
(B) Htr1aRO mice show 
overexpression of Htr1a 
protein in the dorsal 
raphe (DR), median 
raphe (MnR), raphe 
magnus (RMg), and 
raphe pallidus (Rpa). Cb, 
cerebellum. [adapted 
from Audero et al., 2008] 
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 BOX 1- TRANSGENIC MICE DEVELOPMENT 
Mice carrying the gene encoding the tetracycline transactivator (tTA) under 
the control of the endogenous serotonin transporter promoter (Slc6a4tTA) 
were crossed with mice carrying a tTA-inducible allele of the endogenous 
gene encoding Htr1a (Htr1atetO) (Gross et al., 2002). Slc6a4tTA mice were 
produced by replacing portions of exon 2 of the serotonin transporter gene 
starting at the initial ATG (1) with the coding sequence of the tetracycline 
transactivator protein (tTA2) (2) with optimized mammalian codon usage 
followed by bGH polyA sequences and an FRT-flanked pGK-neo cassette 
using gene targeting in W9.5 ES cells. Htr1atetO mice were produced by 
removing the loxP-flanked pGK-neo transcriptional stop cassette from 
Htr1aSTOP-tetO knockout mice (3) by crossing to a germline Cre-deleter strain. 
Htr1atetO allele carried a tetO-CMV promoter (4) targeted into the 5’-UTR of 
the endogenous Htr1a gene and showed tissue expression of Htr1a that was 
indistinguishable from wild-type littermates, although with ~20% less binding 
(data not shown) presumably due to less efficient transcriptional activity of 
the modified promoter. Htr1aRO and control littermate mice were produced by 
breeding +/+; Htr1atetO/Htr1atetO mice with Slc6a4tTA/+; Htr1atetO/Htr1atetO mice 
[for further details see Audero et al., 2008]. 
 
Mice were deeply anaesthetized with isoflurane in a tightly-closed plastic 
chamber (0.5 mL isoflurane, until breathing slowed down to approximately one 
breath per second, and stimulation of the limb withdrawal reflex no longer elicited 
a response), then decapitated using a pair of surgical scissors.  
Preparation of brainstem slices 
Dissection procedure 
In different series of experiments, we have used mice of different age i.e. 20-28 
PND-old mice (young) for patch-clamp recordings, or PND 30-80 mice (adult) for 
loose-seal cell-attached recordings (see below). Conditions for isolation, 
dissection and slicing of the brain from adult (>50 PND old) mice required some 
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 adjustments to increase the rate of success, as described in the dedicated 
paragraph at the end of this section.  
The dissection was carried out in continuously oxygenated (95%O2: 5% CO2) 
ACSF solution (124 mM NaCl, 2.75 mM KCl, 1.25 mM NaH2PO4, 1.3 mM 
MgCl2, 2 mM CaCl2, 26 mM NaHCO3, 10 mM D-glucose pH 7.3 with NaOH, 
320-330 mOsm) cooled with ice blocks of frozen ACSF.  
All procedures to obtain the brain were done quickly (30-50s). The head was 
dipped in ice cold ACSF to clean from the blood and placed in a petri dish with 
ice cold oxigenated ACSF containing blocks of frozen ACSF.  
The skull was exposed by cutting the skin with a small pair of surgical scissors 
from the back of the skull to the nose. Then with the same scissors three other cuts 
were made. The first was along the occipital suture. The second was a caudal-to-
rostral cut along the sagittal suture. The third was across the skull, near the rostral 
end of the second cut. These cuts leave two plates of skull covering each 
hemisphere (Fig. 5A). A small pair of forceps was used to grasp the back of each 
skull flap and lift firmly upward and outward to remove the skull covering each 
hemisphere. This was done carefully to avoid that the temporal lobe got damaged 
by the ventral portion of each plate of the skull. Any extra pieces of skull and 
muscles residuals that did not come off cleanly were quickly removed to prevent 
damage during the brain extraction. After the brain was fully exposed, a smooth 
spatula was inserted along the lateral portion of the brain. Holding the head nearly 
upside down, the spatula was slid under the brain and all cranial nerves were 
severed.  
The brain was then pushed out of the skull cavity onto a piece of filter paper 
inside an ice-packed glass petri dish and dipped in ice cold oxygenated ACSF so 
that dissection occurs at low temperature to slow down tissue metabolism and 
reduce the damage produced by manipulating the brain and slicing. Once chilled 
(1 min), the brain was hold on the parietal lobes (upside down) with the aid of a 
forceps and two coronal cuts were made with a cooled blade. The first cut was at 
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 the level of posterior inferior cerebellar artery. The second cut was under the level 
of internal carotid artery (mid-circle of Willis) (Fig. 5B).  
Preparing brain slices from adult mice (PND 50-80) required particular attention 
to perform the dissection because at this age the skull of the animal is much 
thicker and may result more difficult to remove. Therefore it is necessary to use 
thicker forceps to grip the two plates of the skull to have the necessary force to 
remove them entirely without damaging the tissue. Also, the brain of an older 
animal is much less resilient. To improve the quality of the slices we introduced a 
preincubation stage in which the slices were placed in a holding chamber filled 
with preheated ACSF at 33°C (see below: maintenance of slices before 
recording). 
Slicing procedure 
The midbrain block was carefully taken out of the petri dish with a spatula, the 
caudal part of the block was quickly dried on a paper filter and it was glued 
(cyanoacrylate) on the vibratome tray (vibratome DSK1000, Dosaka). Then the 
tray was placed in the ice cold oxygenated ACSF of vibratome chamber and 
secured. Keeping the brain tissue as cold as possible during slicing is important 
because the vibrating blade penetrates more easily and smoothly when brain tissue 
is made denser and firmer by reducing lipid membrane fluidity. To keep the 
lowest temperature (~4 °C) constant in the cutting chamber of the vibratome, 
some frozen ACSF cubes were left to defreeze into the cutting solution. 
The brainstem region containing raphe nuclei (between -4.24 mm and -5.20 mm 
with respect to Bregma rostrocaudally, according to the atlas of Franklin and 
Paxinos, 1997), was cut coronally with a blade (Biological Instruments SNC, 
Varese, Italy) into three to four slices of 200 µm (Fig. 5C).  
 
 
 
31
  
 
Fig. 5. Mouse Craniotomy and brain dissection. (A) Shows the three cuts made 
on the skull to expose the brain: the cut along the occipital suture, the caudal-to-
rostral cut along the sagittal suture and the cut across the skull, near the rostral 
end of the second one. (B) shows the level of the cuts for isolation of the 
brainstem region containing raphe nuclei. The points of reference for the cuts 
were indicated on the simplified scheme of arterial brain system. (C) Shows four 
Nissl stained slice of 200 µm, corresponding to those obtained for 
electrophysiological recordings and next to each, the relative atlas plate (Franklin 
and Paxinos, 1997). (Upper right), rostral to caudal (from bregma): plate 69, -4.60 
mm; plate 70 -4.72; plate 71, -4.84; plate 72, -4.96. 
DLPAG dorsolateral periacqueductal grey (PAG); LPAG lateral PAG;VLPAG ventrolateral 
PAG; RC raphe cap; Me5 mesencephalic 5 nu; DRD dorsal raphe nu; dorsal part; 
DRVdorsal raphe nu ventral part; DRVL dorsal raphe nu ventrolateral part; DRI dorsal 
raphe interfascicular; DRC dorsal raphe caudal; Aq acqueduct; LDTgV LDTg laterodorsal 
tegmantal nu; mlf medial longitudinal fasciculus; SCP superior cerebellar peduncle; Pa4 
parattrochlear nu. 
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 The angle of the vibratome blade over the tissue surface was ~ 15 degrees which 
is optimal for the blade to progress into the tissue without crushing the surface of 
the brain tissue block or pushing aside the block itself during cutting. 
Maintenance of slices before recording 
Some laboratories have observed that when the slice are cut at ice-cold 
temperature, placed into an incubation chamber at a temperature below 10°C and 
allowed to warm slowly to room temperature nearly every cell is dead (Moyer and 
Brown, 1998). Based on similar observations, a preincubation of slices at 
temperature warmer than room temperature has been suggested to increase the 
probability to obtain healthy cell for patch recording (Borst et al., 1995; Hestrin 
and Armstrong, 1996; Jung et al., 2001; Magee and Johnston, 1995a, 1997).  
Therefore, we have applied the following procedure to help recovery of slices 
from the ice-cold temperature that is most appropriate for cutting the brain tissue 
with a vibratome. Immediately before the first slice was cut, a multiwell 
incubation chamber was filled with oxygenated (95%O2: 5% CO2) ACSF 
solution at 33°C, that was then left to cool down to room temperature (~24 °C) 
once slices were put inside. As each slice was obtained, it was removed from the 
vibratome chamber-bath using a wide-bore (~1 cm diameter) plastic dropper and 
placed with the caudal part face-up (also the recording side) in one well of the 
slice incubation chamber. Slices were maintained at room temperature for 1-6 h 
before being transferred to the recording chamber at 32-35 °C.  
Superfusion of slices and drug application  
For each recording session, one slice was transferred in a custom-made recording 
chamber positioned under an upright microscope (Zeiss Axioskop) equipped with 
x4 air and x60 water immersion objectives (Carl Zeiss, Gottingen, Germany), 
infrared filtered light, Differential Interference Contrast (DIC) optics, a 
Hamamatsu C2400-07 infrared-sensitive charge-coupled device (CCD) camera 
(Hamamatsu Photonics, Hamamatsu, Japan) and a video enhancement device, 
connected to a Hamamatsu thermic-paper printer.  
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 The slice was continuously superfused with ACSF at a flow rate of 2–3 ml/min. 
Superfusion was fed by a peristaltic pump that deliver continuously oxygenated 
(95%O2: 5% CO2) ACSF solution from 100-500 ml flasks to the recording 
chamber, via a small tubing, to reduce the dead-volume. The solution was drained 
from the recording chamber by suction, via a small channel.  
Drugs were applied by changing the flask feeding the peristaltic pump inlet and 
the desired concentration in the flask was obtained by addition of aliquotes of 
drug at appropriate concentration. Aliquotes were either applied directly into the 
graduate flasks containing known volumes of oxygenated ACSF and allowed to 
dilute for 3-4 minutes or diluted in ACSF and placed to oxygenate into the flasks 
at least 15 minutes before being used for superfusion.  
The time required by the solution to reach the recording chamber was 1 minute 
and 20 seconds. The solution was warmed by an inline heater (Warner 
Instruments). The temperature of the solution was kept constant by a temperature 
controller (TC-324, Warner Instruments) connected to the inline heater and 
receiving input from a thermistor placed in contact with the solution within the 
recording chamber.  
Recording setup  
All recordings were done using an EPC10 amplifier (HEKA, Germany). The 
pipette was held in place by an electrode holder containing an AgCl-coated silver 
wire and equipped with a side port to allow application of positive or negative 
pressure to the interior of the pipette. The pipette holder was plugged into the 
headstage of the EPC10 amplifier. The headstage amplifier was attached to a 
keyboard-controlled motorized micromanipulator (Luigs and Neuman, Ratingen, 
Germany) allowing movements of the electrode in three directions (X/Y/Z). 
Signals were digitized using an analog-to-digital data acquisition device on 
EPC10 amplifier and recorded on a PC using Patchmaster software (HEKA 
Germany). 
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 In my experiments I used two different configurations of patch recording (i.e. 
whole-cell and loose-seal cell-attached, (Fig. 6), which allowed obtaining 
different types of information. These configurations will be described in detail 
separately to highlight the principal characteristics of each technique. 
Electrophysiological recording techniques 
Rationale  
Whole-cell recording 
The whole-cell patch-clamp is a recording technique that provides a powerful 
approach for investigating the intrinsic electrical properties of neurons and the 
functional aspects of selected populations of cell membrane channels (BOX 2).  
In this patch-recording configuration, the use of current-clamp mode allows to 
gather crucial information that can be used for the electrophysiological 
identification of a recorded neuron. At the beginning of recording, the pipette 
solution does not alter substantially the intracellular content of the neurone. Thus, 
cell characteristics can be assumed to be still preserved and it is possible to obtain 
reliable measurements of the spontaneous firing pattern and action potential 
waveform of the recorded neuron. Further information can be obtained using 
protocols in which steps of constant current are injected into the cell through the 
recording electrode. Recording cell behaviour during hyperpolarizing or 
depolarizing current steps allows obtaining additional measures of cell membrane 
characteristics (e.g. cell membrane input resistance) or firing behaviour (e.g. 
maximal firing frequency, burst firing at depolarized cell membrane potentials). 
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Fig. 6. Whole-cell and loose-seal cell-attached patch-clamp recording 
configurations. (A) shows a patch-clamp electrode in a typical position to record 
from cells of the dorsal raphe region. (B) shows the configuration of the electrode 
in the two different techniques and the respective firing activity recorded from 
serotonergic neurons. Aq acqueduct, DR dorsal raphe, mlf medial longitudinal 
fasciculus. 
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 BOX-2 WHOLE-CELL PATCH-CLAMP TECHNIQUE - AN OVERVIEW. 
Whole-cell configuration allows application of voltage clamping (VC) to small 
cells with high resolution of recorded currents. Under VC condition 
membrane current is directly proportional to the conductance, i.e. channel 
activity of interest. The principle of the method is to isolate a patch of 
membrane electrically from the external solution (cell-attached recording 
configuration) and then break the patch membrane under the pipette to 
obtain electrical access to the cell interior. This is achieved by pressing a fire 
polished glass pipette, which has been filled with a suitable electrolyte 
solution, against the surface of a cell and by applying light suction to form a 
seal of 10 GΩ resistance. A high seal resistance is needed for two reasons. 
First, higher is the seal resistance, the more complete is the electrical 
isolation of the membrane patch, i.e. the cell. Secondly, a high seal 
resistance reduces the current noise of the recording, permitting good time 
resolution of currents. 
Whole-cell patch-clamp configuration is then obtained by destroying the 
membrane patch using suction. The cell comes into contact with the solution 
in the pipette and could be voltage or current-clamped. As the cell contents 
will equilibrate over time with the pipette solution, it is advisable to use this 
kind of recording over short periods to avoid the loss of responses of interest 
(Fenwick, Marty and Neher, 1982). The result is equivalent to impaling a cell 
with a microelectrode. However, the access resistance is typically much 
lower than what one would obtain with an appropriately narrow conventional 
microelectrode, and the induced leakage conductance is also lower. These 
features allow one to obtain lower noise and higher-fidelity recordings with 
the whole-cell patch technique. The whole-cell voltage-clamp technique has 
the advantage of the nearly complete control of membrane voltage of the 
cell or current through it, thanks to the access of the recording pipette to the 
cell interior. This recording condition however is also the major limit of this 
technique.  
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 In fact the intracellular content is diluted over time by the solution contained in 
the pipette and some important constituents of the cytoplasm could be removed 
or degraded. As a consequence, important features such as 
electrophysiological behaviour and basic properties of the recorded neurons 
can change over time as well. To overcome this problem the recording must be 
relatively brief and the pipette solution composition has to be carefully designed 
to avoid the loss of ATP and GTP dependent processes and more in general to 
delay the inevitable dialysis of cellular content. 
These responses could be used to functionally discriminate different populations 
of neurones as they represent the integrative result of the activity of specific 
channels selectively expressed in different neurones. Further details on the 
parameters that can be obtained with this approach are given below. 
The voltage-clamp mode directly measures the current flowing through cell 
membrane while controlling the voltage. Within the biophysical limits of the 
technique (see BOX 2), the possibility of closely controlling cell membrane 
potential becomes crucial for the study of characteristics and responses of voltage-
gated ion channels. Even ion channels gated by ligands, including the 5-HT1A 
receptor-sensitive that are gated by a G-protein and therefore nominally “voltage-
independent”, a voltage dependence is often seen and electrical measurements are 
much easier to interpret if the voltage is held constant. Furthermore, for both 
voltage-gated and ligand-gated channels, the voltage sets the driving force for 
current through the membrane, so that when the voltage is fixed, the current 
reflects the number of open channels. Thus, by applying this technique combined 
with the use of pharmacological tools, the activity of specific groups of channels 
can often be studied in detail. 
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 Experimental procedures 
Intracellular patch pipette solutions 
Throughout the present study, pipette solutions were designed to preserve as far as 
possible the physiological composition of the intracellular “milieu”. However, 
some adjustments were introduced to the composition of the solution when 
required by experimental needs. 
In a first set of  experiment carried out at 28°C, patch-pipette solution was 
comprised of (in mM): KMetSO3 120, KCl 15, HEPES free acid 10, MgCl2 2, 
GTP-Na3 0.3, Na2-Phosphocreatine 10, ATP-Mg 4 (pH 7.3 with KOH, osmolarity 
320-330 mOsm).  
However, when we performed experiments at temperature above 31 °C (31-35°C), 
we observed that the patch was subject to re-sealing and recordings resulted of 
lower quality.  
Therefore in the following set of experiments, in which the temperature of the 
superfusing ACSF was set above 30 °C (typically 33-35 °C) we added a low 
concentration of EGTA (50 µM) to a very similar pipette solution (in mM): 
KMetSO3 120, KCl 15, HEPES free acid 10, MgCl2 2, EGTA-K4 0.05, GTP-Na3 
0.3, Na2-Phosphocreatine 10, ATP-Mg 4 (pH 7.3 with KOH, 320-330 mOsm). A 
small amount of EGTA buffers calcium ions stabilizes the membrane patch and 
improves quality of recording at temperature higher than 28°C, while introducing 
undetectable, if any, alteration of electrophysiological cell behaviour. 
When the protocol required labelling of the recorded neuron with a fluorescent 
dye to allow subsequent identification of the cell by means of 
immunohistochemical methods (see dedicated section below) either lucifer yellow 
CH potassium salt 2 mM or Alexa Fluor 488 hydrazide sodium salt 300 µM were 
added to a solution comprised of (in mM): KMetSO3 120, KCl 15, HEPES free 
acid 10, MgCl2 2, EGTA-K4 0.05, GTP-Na3 0.3, Na2-Phosphocreatine 10, ATP-
Mg 4 (pH 7.3 with KOH, 320-330 mOsm). These solution, allowed marking the 
recorded neuron with a high concentration of the fluorescent dye, which 
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 facilitated subsequent post-hoc identification of the recorded neuron in the thick 
(200 µm) slice.  
Finally, we found that the substitution of KMetSO3 with K D-Gluconate as 
impermeant anion in the pipette solution increased the duration of stable recording 
and therefore we adopted the following pipette solution as a standard (in mM): K 
D-Gluconate 120, KCl 15, HEPES free acid 10, MgCl2 2, EGTA-K4 0.1, GTP-Na3 
0.3, Na2-Phosphocreatine 10, ATP-Mg 4 (pH 7.3 with KOH, 320-330 mOsm). 
The use of this pipette solution allowed stable and reliable recordings for longer 
than one hour at temperature near 33°C. 
Patch pipettes 
Patch pipettes were fashioned with a four stage process on a P-97 micropipette 
puller (Sutter Instruments, Novato, CA) using borosilicate glass capillary tubing 
(1.5 mm o.d., 1.17 mm i.d.; Clark Electromedical Instruments) and had resistance 
of 2–3 MΩ when filled with pipette solution (previously filtered with 0.2 µm 
syringe filter). 
Placement of the slice in the recording chamber and selection of recording field 
under visual guidance with IR-DIC microscopy 
One slice was taken from the holding chamber and placed in the recording 
chamber and held in place by a net on top of the slice. This securing net was made 
with five single strands of nylon hosiery glued across a platinum U-shaped wire 
using cyanoacrylate. When placed on the slice, the nylon hosiery serves to anchor 
the slice around the region of interest. 
After securing the slice, the dorsal raphe region was positioned in the center of the 
microscope field of view using the low magnification (x4) objective. 
Subsequently, the slice was examined using a water immersion objective (x60) 
and the neuron was selected for recording, based on its appearance under IR-DIC 
microscopy. Dorsal raphe neurons were identified as being probably serotonergic 
by their location along the midline, ventral to the Aqueduct of Sylvius and by 
their size and shape (medium to large, i.e.15–20 µm to 20–30 µm, bipolar or 
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 multipolar cells). An apparently healthy neuron laying at 30-90 µm from the 
surface of the slice was then chosen and targeted for recording.  
Patch-clamp procedure 
After connecting the pipette holder to the amplifier headstage, a positive pressure 
was applied to the pipette by blowing air (~4 ml) with a syringe connected to the 
pipette holder via a Tygon or Nalgene (Fisher Scientific, Pittsburgh, PA) tube 
plugged into a three-way valve. Then, pressure was mantained by closing the 
three-way valve.  
The electrode was placed in the bath solution and the potential difference between 
the tip of the electrode and the Ag/AgCl reference electrode (in contact with the 
bath solution) adjusted to zero. In voltage clamp mode, with the command 
potential set to 0 mV, 5 mV hyperpolarizing voltage steps were applied. Based on 
the measured step current, the pipette resistance is calculated from Ohm’s law. 
Once the neuron of interest was visualized, the pipette was lowered under the 
objective and positioned near the selected neuron using the micromanipulator. 
Then the tip of the pipette was directed towards the cell until a dimple appeared 
on the surface of the neuron. At this point the positive pressure was released and 
the electrode retracted slightly. When the maneuvre was successful the electrode 
resistance increased dramatically, either spontaneously or with the aid of gentle 
suction applied to the interior of the pipette, i.e. a gigaohm seal formed between 
the electrode and the cell membrane. 
The command potential of the amplifier in voltage clamp mode was maintained at 
-65 mV. Capacitive transients due to the electrode capacity were cancelled using 
the Cfast dial on Patchmaster software. Brief pulses of suction were applied to the 
interior of the pipette to break the cell membrane under the pipette and to obtain 
access to the whole-cell. The access resistance was monitored for judging the 
stability of recording and the capacitive current transient due to the membrane of 
the cell was cancelled using the Cslow dial on Patchmaster software. 
After waiting for 3–5 min, to allow for neuron dialysis with the pipette solution, 
we transiently switched to a current-clamp configuration to record the membrane 
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 potential and to confirm the identity of serotonergic neurons by recording 
responses to negative and positive current pulses and subsequently to monitor the 
action of tetrodotoxin (TTX) when applied. 
Series resistance was assessed from the peak value of current produced by an 
application of small (-10 mV) voltage steps according to Ohms Law (R=V/I).  
Recordings were accepted if the series resistance was ≤ 20 MΩ and did not 
change during the experiment. If either the amplitude or shape of the 
hyperpolarization-evoked transients changed abruptly, the experiment was 
discarded. The liquid junction potential was not corrected.  
At the end of recording, the position of recorded the cell was photographed using 
the Hamamatsu infrared CCD camera and the image taken as photomicrograph. 
The cell position relative to midline acqueduct was measured from these images. 
All the cells recorded were found between 600 µm from aqueduct along the 
midline and 300 µm maximum lateral to midline. 
Whole-cell recording: current-clamp and voltage-clamp protocols 
In whole-cell recordings we collected a series of parameters useful to characterize 
the recorded cell and its activity under control conditions and during the 
application of drugs.  
Since one of the aims of the present work was to identify electrophysiological 
parameters which would permit to distinguish between serotonergic and non 
serotonergic neurons on the basis of their spontaneous or pharmacologically-
stimulated activity, the information obtained in current-clamp is of great interest. 
In fact, using appropriate protocols, it would be possible to explore some 
integrated functional characteristics (e.g. action potential characteristics, 
maximum rate of action potential discharge) that may result specific of each type 
of neuron, and that cannot be recorded in voltage-clamp conditions. Thus, the 
electrophysiological protocols applied were designed to measure different 
parameters in current-clamp or voltage-clamp conditions, as described below. 
Whenever required, drugs were bath applied. 
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 Current-clamp 
In current-clamp the spontaneous discharge of action potentials (when present) 
was recorded for 1-3 min to permit analysis of the firing frequency and to obtain a 
sufficient number of spontaneous action potentials for measurement of their 
relevant parameters (e.g. action potential amplitude, duration). Occasionally, 
when the cell was not spontaneously active, a small positive current was injected 
through the recording electrode to elicit action potential firing. Appropriate 
protocols were applied to investigate the total input resistance (Rin) of cells and 
their membrane I/V response. Rin and the I/V relationship were measured by 
applying negative constant current steps of increasing intensity and 1-3 s duration, 
and measuring the resulting hyperpolarization of the cell at the end of the current 
steps.  
The negative current steps were programmed to hyperpolarize neurons up to a 
membrane potential of -115/120 mV (if allowed by the characteristics of 
recording electrode). At this membrane potential, the presence of a sag which 
develops during the step is interpreted as a relative depolarization produced by the 
activation of a voltage- activated cationic current (IH). To accurately detect the 
presence of a depolarizing sag and measure its amplitude, we acquired a series 
(n=5-7) of negative current steps (typically -20/-40 pA) adjusted so that the 
negative peak of the cell membrane potential during the step reached -115 to -120 
mV from a cell membrane potential held at -70 mV. Series of square positive 
current steps of 1-3 s duration and increasing intensity were injected in recorded 
neurons to elicit action potential firing. The intensity of the depolarizing current 
was increased at each following step until the firing rate of the recorded cell 
reached a maximum, became irregular or stopped.  
A further parameter investigated in most of the recorded cells was the sensitivity 
to 5-HT1A receptor activation. The typical electrophysiological response to 
stimulation of 5-HT1A receptors is the opening of G protein-coupled inwardly 
rectifying potassium (GIRK) channels and hyperpolarization of the recorded cell. 
To determine the effect of the selective 5-HT1A receptor agonist R-8-OH-DPAT 
(1-300 nM) on membrane potential, continuous recordings were conducted in 
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 current-clamp mode with no current injection (voltage follower). A similar 
protocol was used to measure the effect of α1-adrenoceptor activation by 
phenylephrine (10 µM).  
Voltage-clamp 
In voltage clamp, voltage steps of -10 mV, 100 ms long, were imposed from a 
holding potential of -60 mV, this protocol was used to determine the access 
resistance, the cell membrane resistance and the membrane/leak current present at 
“rest”. Measurements of access resistance were carried out by averaging five 
traces in which negative voltage step was delivered through the recording 
electrode. Access resistance was calculated as the ratio between the averaged 
capacitive current peak response and the applied voltage step (-10 mV). 
To more directly determine the GIRK current evoked by perfusion of R-8-OH-
DPAT, voltage-clamp recordings were conducted in the presence of TTX. 
Neurons were clamped at -60 or -65 mV and currents were elicited by applying 
repetitive voltage ramp commands (0.1 V/s) to -120 mV at varying intervals. 
Acquisition parameters 
In current-clamp recordings, signals were digitized at 25 kHz and low-pass 
filtered at 8 kHz, in voltage-clamp recordings, signals were digitized at 10 kHz 
and low-pass filtered at 3 kHz. 
 
Rationale  
Loose-Seal Cell-Attached Recording  
To observe the “physiological” firing pattern(s) of individual neurons requires 
recording techniques that can monitor cell activity without producing any 
mechanical or intracellular fluid perturbations. 
Common recording methods as whole-cell patch-clamp and cell-attached patch-
clamp techniques have been widely used for this purpose, but they are far from 
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 being the best suited choices. Their application in fact can result in the severe 
alterations of the cell, such as the deformation of the membrane to obtain a tight 
seal or the dialysis of the cell internal environment caused by the exchange with 
pipette solution in whole-cell configuration. 
The loose-seal patch-clamp is a variant of the more popular cell-attached patch-
clamp technique and permits to record the endogenous activity of a neuron for 
several hours without affecting the cell behaviour. At variance from cell-attached 
patch-clamp, this technique does not require special processing of the tissue to be 
achieved. The formation of a low resistance seal (<20 MΩ) on the surface of the 
target cell can avoid the process of “cleaning” necessary for the tight seal, and 
does not compromise the integrity of the cell membrane as a consequence of 
excessive suction. Furthermore, as the cell membrane remains integer, the 
physiological intracellular milieu also is maintained intact.  
Finally, loose-seal cell-attached recording has a practical advantage over the tight-
seal technique regarding the use of voltage-clamp mode to record firing rate 
activity. In fact, in tight-seal even few picoamperes injected by the amplifier can 
affect the patch membrane voltage, as the seal resistance is several magnitudes 
greater than the patch resistance, and therefore all the current generated by the 
amplifier would pass across the membrane patch. Thus in tight-seal the amplifier 
voltage command must imperatively be set at the correct value of membrane 
potential and continuously monitored, to ensure that no current is delivered to the 
patch-membrane. This is not always practical when drugs are applied, since they 
could change cell membrane potential and in general there is always the risk to 
affect the activity of the recorded neuron.  
In contrast, loose-seal patch-clamp operates with seal resistances of few MΩ, i.e. 
lower than the patch resistance. Thus, even if amplifier generates some current 
due to incorrect estimate of the cell membrane potential or to a small drift of the 
reference, the current injected into the pipette by the amplifier in the attempt to 
counteract these erroneously estimated changes in cell membrane potential, would 
pass across Rseal, without affecting the cell activity.  
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 Eventually, the extracellular recording of neuron firing rate using loose-seal cell-
attached technique could seem similar to the single unit extracellular recordings 
with microelectrodes. However, we have observed under IR-DIC microscopy at 
high magnification that, to obtain a signal using sharp microelectrodes (~10 MΩ), 
the electrode should touch tightly cell membrane and this may elicit the formation 
of a large dimple on the surface of the cell. When observed this dimple expanded 
overtime, eventually changing the morphology of the neuron. As a severe 
deformation of the membrane may occur, in these cases the experimenter cannot 
be confident that the physiological cell activity was not altered by such a 
modification. Therefore we have chosen the loose-seal patch-clamp technique as it 
results one of the least invasive electrophysiological methods available and 
ensures very reliable and quite stable recordings in nearly every condition. 
Experimental procedures 
Visually-guided loose-seal cell-attached recordings were obtained using the same 
equipment and superfusion arrangement as for whole-cell recordings. Thus, slices 
were submerged in standard ACSF solution saturated with 95% O2, 5% CO2 gas 
at 33-35°C. When appropriate, ACSF was supplemented with a cocktail of 
receptor antagonists to block synaptic neurotransmission.  
Loose-seal patch-clamp pipette solution 
Loose-seal cell-attached recording electrodes were pulled from the same 
borosilicate glass capillaries used for whole-cell configuration, and had 
resistances of 2–3MΩ. The pipette contained 150 mM NaCl solution or a HEPES 
based ACSF-like solution comprised of (mM): 124 NaCl, 2,75 KCl, HEPES 10, 
CaCl2 2, MgCl2 1,3 and pH 7.4 with NaOH. 
A sodium-based pipette solution with a composition nearly similar extracellular 
ACSF is used to avoid the perturbation of neuronal activity during recording. It 
allows the experimenter to clean the cell membrane by blowing solution out of the 
electrode tip before a seal is attempted, without depolarizing the cell and possibly 
weakening it. Pipettes were filled with NaCl saline solution in early studies. 
Because this is a non buffered solution, we became concerned that it could 
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 influence the stability of recording over time. We thus switched to normal HEPES 
solution for later studies. No significant difference was observed in recording 
firing activity between these pipette solutions. We found pipettes with resistances 
of 2-3 MΩ when filled with normal HEPES pipette solution and held at potential 
of which amplifier read 0 pA current more suitable for these recordings. When 
pipette resistance was > 3 MΩ, we found the diameters to be too small, and GΩ 
seals often spontaneously formed. Conversely, pipettes < 1 MΩ were so large in 
diameter that cell morphology could be affected. In our experience, electrode 
resistance was the primary determinant of recording success. 
Patching procedure 
To approach the target cell, minimal positive pressure was applied to the 
recording pipette, which was then lowered into the bath and moved to a position 
above the surface of the slice. By focusing back and forth between the target cell 
and the pipette tip, the pipette was moved into position above the slice surface 
directly close to the target cell. Readings of pipette resistance and pipette offset 
were taken at this time. The pipette was then moved along an oblique trajectory 
and downward through the slice, to avoid the compression of the tissue over the 
cell. Positive pressure was then slowly released and usually a loose-seal between 
the recording pipette and the cell membrane was obtained.  
To measure the seal resistance in voltage-clamp, voltage step of -10 mV, 40-100 
ms long, were elicited from a holding potential that gives 0 pA current in current-
clamp mode. Within 5-min, seal resistances typically ranged from 8-12 MΩ and 
either remained stable or increased slowly over time up to as high as 40 MΩ. 
These seals typically formed spontaneously and did not require application of 
negative pressure (suction) by mouth. Occasionally, when no spontaneous activity 
and no change in pipette resistance were observed in the first 5-min we applied 
negative pressure to improve seal resistance.  
Recording quality checks 
The typical firing pattern of serotonergic neurons was monitored under voltage-
clamp using continuous recording. We checked periodically for seal resistance 
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 during recording. Occasionally, seal resistance raised and reached the 100 MΩ 
range. To reveal if the recording would have been affected by the command 
voltage in these conditions, ramps of voltage steps were applied. As mentioned 
above, in the case of an appropriate loose-seal cell-attached configuration, 
injection of current through the pipette should not affect the spontaneous cell 
activity because the current injected should outflow through the loose patch (i.e. 
Rseal). Thus, if these current ramps produced a change in neuron firing rate, the 
recording was considered unreliable and it was aborted.  
During the recording we also checked for stability of the baseline current. 
Typically, the trace would shift very little and very slowly once set to 0 pA. If any 
appreciable change in baseline occurs, we used the pipette offset command to shift 
the baseline to 0 pA as needed to negate current. 
 
Acquisition parameters 
In loose-seal cell-attached recordings, signals were acquired in continuous 
voltage-clamp mode with a gain of 10-20 mV/pA, digitized at 10 kHz and filtered 
at 3 kHz. To obtain more precise measures of action current parameters, signals 
were also acquired with a higher sample rate i.e. digitized at 100 kHz with a gain 
of 20 mV/pA and filtered at 8 KHz. The same acquisitions were done in current-
clamp; no difference in kinetics was noticed between the signals recorded in these 
two modes. 
CO2/pH challenge experiments in loose-seal cell-attached 
To investigate the response of serotonergic neurons to changes in extracellular 
concentration of CO2 and pH, the experiments were performed using a modified 
oxygenating system.  
Standard ACSF solution (i.e containing 26 mM NaHCO3) was bubbled in three 
reservoirs, each one with a different mixture of O2 and CO2 which resulted in 
solutions having a different CO2 content/pH (control solution: 95% O2, 5% CO2 
pH ~7.4; hypercapnic, lower pH, solution contained 9% CO2 and hypocapnic, 
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 higher pH, contained 3% CO2). The pH of oxygenated solutions was measured 
with a pH electrode before starting the experiment. In reporting the results, CO2 
values are given instead of pH, because CO2 was experimentally controlled as the 
independent variable. When CO2, was increased from 5% to 9%, there was 
typically a decrease in pH of 0.22-0.25 from the baseline pH of 7.4. Changes in 
CO2/pH, were made by switching the feeding-perfusion tube between the three 
reservoirs. Changes in CO2 were limited to the range of 3-9%, because levels 
beyond this range would be unlikely to occur under physiologic conditions.  
Baseline firing pattern was recorded typically for 10-15 minutes before 
application of ACSF with different mixture of CO2/O2 (15 minutes). When the 
effects of 3% and 9% CO2/O2 on the same cell were tested, a recovery period of at 
least 15 min in normal CO2/O2 mixture (95% O2, 5% CO2 pH ~7.4) was left 
between applications.  
As mentioned in the introduction and aims of this work, the principal objective of 
my studies was to characterize the functional modifications of serotonergic neuron 
activity using in vitro electrophysiological approaches in mutant mice in which 
overexpression of 5-HT1A receptors was selectively induced in serotonergic 
neurons of the raphe. This involved the need to identify serotonergic cells during 
each electrophysiological experiment using their intrinsic characteristics and 
whenever possible using one distinctive parameter that could be recorded in 
whole-cell as well as in extracellular loose-seal cell-attached configuration. 
Identification of serotonergic cells using electrophysiological parameters  
Thus, in the initial phase of my thesis I studied the electrophysiological properties 
of serotonergic cells in non mutant, C57bl/6, mice. Serotonergic cells were 
identified with the use of whole-cell recordings combined with 
immunohistochemistry for L-tryptophan hydroxylase II (TpH 2) as a selective 
marker (Fig. 7). Several possible candidate parameters were investigated and in 
this section. 
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 I will illustrate those that better characterize serotonergic cells in whole-cell 
recordings and that can be used to identify the recorded cell as a serotonergic 
neuron also in extracellular loose-seal cell-attached configuration.  
Differences between serotonergic and non serotonergic neurons 
Serotonergic neurons have several distinctive morphological, anatomical, and 
functional properties that, when considered together, allow to distinguish them 
from non serotonergic neurons. Serotonergic cells have a large soma (20-30 µm) 
of variable morphology and are localized predominantly along the midline of 
dorsal raphe region while non serotonergic neurons have smaller soma (10-15 
µm), usually of bipolar shape, and are more dispersed throughout the raphe 
region.  
When stimulated by α1-adrenoceptor activation, serotonergic neurons display 
relatively slow and regular firing (0.1-4 Hz) with low variance in firing rate 
(typically of 5-20%), whereas non serotonergic neurons discharge with a wider 
range of firing  
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Fig. 7. Photomicrographs of TpH2-immunoreactive (5HT-neuron) and non TpH2-
immunoreactive neurons (non 5HT-neuron), labelled with injection of a fluorescent dye. (A1, 
B1) recorded neurons labelled with Alexa fluor 488 (300 µM) are shown by arrows. 
Immunohistochemistry for tryptophan hydroxylase (TpH2) identified the label neuron as 
serotonergic (A2, TpH-ir) or not serotonergic (B2, non TpH-ir), see arrows. (A3,B3) merged.  
A1 B1 
A2 
A3 
B2 
B3 
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 rates (0.1-20 Hz) and often their firing is highly irregular with variance up to 
100% (Fig. 8).  
When directly stimulated by a series of steps current injection of increasing 
intensity, serotonergic neurons preserved their slow firing regularity reaching a 
constant firing rate level. Non serotonergic neurons increased their firing rate 
much more linearly with increase in the injected current and often did not show a 
plateau but cessation of firing (Fig. 9). 
Furthermore, serotonergic cells possess basic properties (i.e. conductances) that 
underlie generation of action potential as well as its shape and duration, that are 
distinctive amongst cells of the dorsal raphe and that could be used to distinguish 
them from non serotonergic neurons. Thus, serotonergic cells have a broad action 
potential, with a shoulder during the repolarizing phase and a large slow-
afterhyperpolarization (Fig. 7A, Fig. 10A1, see also Fig. 12 for details). In 
contrast, non serotonergic cells have shorter action potential and shorter AHP 
(Fig. 1B). 
A further prominent difference is the fact that non serotonergic cells express HCN 
channels, which are not (or very weakly) expressed by serotonergic cells. Thus, 
non serotonergic cells have a substantial IH current that is strongly activated at 
hyperpolarized cell membrane potentials and is revealed by a marked sag in the 
hyperpolarization produced by a step of negative current in whole-cell recordings 
(Compare Fig. 10B2 with 10B1 in a serotonergic cell). 
Another distinctive property of serotonergic cells that is relevant to the present 
investigation is their high sensitivity to 5-HT1A receptor activation. In fact, 
serotonergic cells respond with a marked hyperpolarization and decrease in firing 
rate to the application of relatively low concentration (10-30 nM) of selective 
5-HT1A receptor agonists (R-8-OH-DPAT or 5-CT), whereas non serotonergic 
cells show a weak, if any, response to these agonists, even when applied at very 
high concentration (100-300 nM) (Fig. 11).  
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Fig. 8. Characteristical firing patterns of serotonergic and non serotonergic 
neurons. Panel (A) photomicrograph of the fluorescent dye labeled cell shown in 
Fig. 7A1-3, immunoreactive for TpH2 and traces of the respective action potential 
waveform and spontaneous firing rate recorded in whole cell (upper traces). 
Lower traces show the typical action current waveform and the pattern of firing 
recorded with loose-seal cell-attached recording from a serotonergic neuron. (B) 
the same set of information is shown as in (A) but for the non serotonergic cell in 
Fig. 7B1-3 (scales: action potentials 10 mV-1ms; firing in whole cell, 10 mV-2 s; 
action current, 50 pA-1ms; firing rate in loose seal cell-attached patch clamp, 50 
pA/2 s). 
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Fig. 9. Typical response of a serotonergic (A) and a non serotonergic (B) neuron 
to a series of depolarizing current steps injected through the recording electrode. 
(A) Slow and regular firing response of serotonergic neuron to injections of 
increasing current. Scales: 20 mV-1 s (B) response of a non serotonergic neuron. 
Scales: 20 mV-500 ms. Note that for injection of comparable current steps, the 
behaviour of the two cells were strikingly different. However, it should also be 
noted that the activity of the non serotonergic cell was regular and could be 
wrongly interpreted as serotonergic cell displaying a fast firing rate, but the two 
cells are discriminated by the action potential duration (see Fig. 13). 
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Fig. 10. Action potential waveforms and responses to hyperpolarizing current 
injections in a serotonergic (A) and a non serotonergic cells (B). (A1) typical 
broad action potential with shoulder (see inset) of a serotonergic cell, that shows 
a large afterhyperpolarization. (B1) typical action potential waveform of a non 
serotonergic cell; (A2, B2) response to negative current injection that revealed a 
prominent sag in a non serotonergic cell (B2) and the absence of sag in a 
serotonergic cell (A2). Scales: insets 10 mV-1ms; (A2, B2) 10 mV-200 ms. 
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Fig. 11. Response of a serotonergic and a non serotonergic neuron to application 
of the 5-HT1A receptor agonist 5-CT in loose-seal cell-attached recording. (A) 
Time-course of instantaneous firing frequency showing the absence of response 
to 5-CT 100 nM in a non serotonergic neuron. (B) Time-course of the 5-CT 
concentration dependent inhibition of firing rate in a serotonergic neuron. Note 
that cessation of firing is reached with 5-CT 10 nM. Insets: action current 
waveforms, scale: 20 pA-1s. 
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 Although any of these parameters is eventually useful for identification of 
serotonergic cells, the analysis of action potential waveform offers the most 
practical and immediate parameter for the identification of the recorded cell and, 
in most of cases, is sufficient for conclusive neuronal type identification. 
Therefore in the present study we used the action potential waveform to 
distinguish between serotonergic and non serotonergic cells. In addition, as we 
used an extracellular recording technique, the loose-seal cell-attached patch 
clamp, to monitor the firing behaviour of raphe neurons, I will describe the 
characteristics of the signal obtained with this technique and the meaning of its 
different phases in relation to the waveform of action potential recorded in whole-
cell. 
Action potential waveform analysis in whole-cell recording 
Monoaminergic neurons display a long action potential with a plateau (shoulder) 
during the repolarizing phase that is absent in non serotonergic cells. The best 
suited parameter describing the duration of the action potential is its half height 
width of action potential (HHW). HHW can be defined as the time interval 
between the rising phase and descending phase of AP peak at the half point 
between peak amplitude and antipeak (negative peak) amplitude potentials (Fig. 
12).  
In C57bl/6 mice, HHW values of action potential in serotonergic cells are 
typically in the range of 1-3 ms while those of non serotonergic cells are 
comprised between 0.3 and 0.9 ms.  
Considering that in loose-seal cell-attached patch-clamp the recorded waveform 
closely reproduces the kinetics of the neuronal action potential and can 
theoretically be approximated by the first derivative of the action potential 
recorded in whole-cell (see BOX 3), it becomes sensible to compare the action 
potential recorded in whole-cell with its first derivative, so to better understand 
the meaning of the different phases of the extracellularly recorded action current 
waveform. 
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Fig. 12. Determination of the Half Height Width parameter (HHW). The 
measurement of action potential half-height is shown on the waveform recorded 
with a slow timebase to show the entire sequence of events preceeding and 
following action potential. inset: enlarged action potential. Double arrow shows 
the time interval taken as measure of HHW of the action potential. 
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 As shown in Fig. 13, the first derivative in time (dV/dt) of the action potential 
presents peaks that correspond to points of maximal velocity of depolarization 
(Upstroke) and maximal velocity of repolarization (Downstroke). As action 
potentials have different shape in serotonergic and non serotonergic cells, their 
first derivative are also different. Non serotonergic cells display prevailingly a 
dV/dt with two peaks, one Upstroke and one Downstroke. Serotonergic neurons 
typically display three peaks, one Upstroke and two
Thus, the measure of the interval between the upstroke and the downstroke(s) 
(Upstroke / Downstroke Interval: UDI) of the first derivative of the action 
potential recorded in whole-cell current-clamp, permits to quantify the duration of 
action potential. As illustrated in Fig 13B2,B3, in serotonergic neurones showing 
two downstrokes, the UDI parameter should be measured as the time interval 
between the Upstroke and the 
 Downstrokes.  
second
In conclusion, since the signal recorded in loose-seal cell-attached corresponds to 
the first derivative of neuron action potential, the parameter UDI measured on 
action current recorded in loose-seal cell-attached patch-clamp configuration 
closely reports the duration of action potential, that is distinctive of cell type and 
can be used to distinguish between serotonergic and non serotonergic neurons (see 
Fig.13B3 vs A3). 
 Downstroke this is indicated by UDI2 in Fig. 
13B2 and 13B3, but for clarity I will refer to UDI throughout the following 
paragraphs. As shown in Fig. 14, UDI correlates in a very good manner (1:1 ratio) 
with the HHW of action potentials (UDI > 0.9 ms for serotonergic cells). 
Although the correlation between UDI and HHW is less strong in non 
serotonergic cells (UDI <0.9 ms; not shown) it appears clear that UDI >0.9 is 
distinctive of serotonergic cells and therefore can be safely used to identify these 
cells during recording.  
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Fig. 13. Determination of Upstroke to Downstroke Interval UDI (UD2I) parameter 
on the first derivative in time of action potential recorded in whole cell and on 
action current recorded in loose seal cell-attached. (A1-.3) is shown the half-
height width (HHW) of the action potential recorded in whole-cell (A1) from a non 
serotonergic cell is compared with its first derivative (A2) and with the waveform 
recorded in loose-seal cell-attached mode. Note that the first derivative of the 
action potential closely resembles the action current recorded in loose-seal cell-
attached. In (A2, A3) also shows how the UDI parameter on the first derivative in 
time of action potential and on action current is measured. (B1-3) show the 
corresponding traces and measures for a non serotonergic neuron. Note that, 
due to the presence of a shoulder during the repolarizing phase of action 
potential the first derivative in time of action potential and the extracellular 
recorded signal show two downstrokes and the measures are taken on the 
second (UD2I). 
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Fig. 14. Correlation between action potential Half Height Width parameter (HHW) 
and Upstroke to downstroke interval of the first derivative on time (UD2I) of the 
action potential. The correlation of HHW and UD2I (UDI) (UD2I/ HHW= 1.02 ± 
0.06, 95%CI 0.91-1.14,  r2=0.88; n=45). 
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BOX 3 THE SIGNAL RECORDED IN LOOSE-SEAL CELL-ATTACHED PATCH-CLAMP: 
THEORETICAL CONSIDERATIONS ON ITS ORIGIN AND SIGNIFICANCE 
This section reports a semiquantitative analysis that explains the origin of loose-
seal recorded signal shape and the relationship between the extracellularly 
recorded signal (potentials/currents) and the transmembrane electrical events 
that originate extracellular signal.  
In a simple spherical neuron the current generating an action potential (Im) flows 
across an inactive region (where action potential is going to be generated), will 
consists of both capacitive and resistive components: Im= IC + IR = Cm (dVm/dt) + 
Gm Vm, where Vm is the transmembrane potential, Cm is the membrane 
capacitance, and Gm is the conductance of the inactive region of the membrane. 
Because the transmembrane current Im draws current from the extracellular 
space, the time course of the inward current in the inactive region of the 
membrane will dictate the timecourse of extracellular potential (Vext) across the 
extracellular space (i.e. across a resistance, Rext). The time course of the 
extracellular recorded potential will be roughly proportional to Im, or Vext ∝ Im.  
For electrical events that are relatively fast with respect to the membrane time 
constant (e.g. action potential t >> τm), most of the current exiting in the 
extracellular space will be capacity current across the active region (where action 
potential has been generated). Thus for fast conductance change (∆Gm fast 
respect to τm) the timecourse of the extracellular potential is roughly proportional 
to the first derivative of the transmembrane potential, or Im ∝ dVm/dt ∝ Vext 
(Humphrey et al., 1990; Johnston et al., 1995). 
Therefore, loose-seal signal recorded in voltage- or current-clamp will have the 
same time-course but different polarity, the current recorded will be in the order of 
hundreds (to one thousand) of picoamperes and the voltage of few millivolts.  
In conclusion, the extracellular potential/current recorded in loose-seal cell-
attached patch-clamp will be closely proportional to the first derivative of 
transmembrane voltage.  
 
 
 Acquisition and analysis of electrophysiological parameters  
Whole-cell recording 
To distinguish between cells we preferably recorded spontaneous generated action 
potentials. If the cell did not fire spontaneously, we measured action potential 
parameters on action potentials evoked by the injection of steady current of 
minimal intensity (2-10 pA) or we used action potentials discharged on rebound 
depolarization that often follows an hyperpolarizing pulse. Action potentials were 
acquired at 25 kHz and detected with Clampfit proper procedure, setting the 
baseline at rest potential and the threshold at two third of AP amplitude. 
Individually detected events were peak-aligned and their average was used to 
measure HHW and UDI parameters. 
Analysis of other parameters  
From current-clamp and voltage-clamp recordings the following parameters were 
determined to characterize serotonergic neuron intrinsic properties: 
• Membrane potential measured at break of patch in spontaneously firing 
cells. The following procedure was used to obtain an estimate of “resting” 
membrane potential (RMP): RMP  was determined by interpolation from 
IHOLD and RIN measured on negative voltage step, 1mV/measured Rcell 
GΩ= unit pA; measured Ihold pA/unit pA= XmV, RMP=(-65 mV Vhold) 
+ X mV),  
• Membrane resistance RIN was measured according to Ohm’s law 
R=∆V/∆I, from the average of five negative voltage steps, as the mean 
value of last 40 ms of the elicited current pulse.  
• Membrane capacitance CM (determined online by a “macro” of the 
acquisition software fitting an exponential decay curve to the 
uncompensated membrane capacitive current transient, elicited by the 
voltage step),  
• Time-dependent depolarization of hyperpolarizing current step, 
depolarizing sag or Vsag (determined from the largest hyperpolarizing step 
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 as the difference between the average potential of the last 200 ms and the 
potential peak between the first 250 ms, Vsag= Vend-Vpeak). 
• Quantification of 5-HT1A receptor-mediated activation of GIRK 
conductance by selective agonists (e.g. R-OH-DPAT). This was done as 
follows: ramps of negative potentials were imposed to the neuron 
membrane potential under voltage-clamp mode in the absence (control) 
and in the presence of the agonist. After digital subtraction of the control 
from the response in the presence of the drug, the I-V relationship between 
-85 and -95 mV was fitted by linear regression and the slope taken as the 
peak conductance.  
Loose-seal cell-attached recording 
Loose-seal recordings were high pass filtered with a bessel (8 pole) filter set at cut 
off frequency of 5 Hz. We used Clampfit (Axon Instruments) to detect and 
analyze the recorded action currents events. The instantaneous firing frequency 
obtained was collected to plot a time-course of each experiment. 
Waveforms for identification of the cells were preferentially obtained from the 
earliest recording acquired with high gain and digitized at 100 kHz. When this 
recording was not available the average waveform of 1 minutes of early standard 
recording was taken. The waveforms of single events were collected at 40 ms 
before the upstroke and 100 ms after. The collected events were aligned at peak 
and the UDI parameter was measured on the average. The spontaneous firing rate 
FR, or the firing rate recorded after bath application of phenylephrine if the cell 
did not spontaneously discharge action potentials in normal ACSF, was measured 
as number of events over 1 or 3 seconds of stable recording. 
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 Analysis of responses to perfusion of drugs 
Pharmacology 
All experiments in loose-seal cell attached recording in voltage clamp mode were 
carried out in ACSF supplemented with antagonists that block synaptic 
transmission (“cocktail”) to isolate single cell activity from network.  
The concentration-response curves for agonists (e.g. R-8-OH-DPAT, 5-CT) were 
obtained using cumulative concentration-response protocols. Drugs were applied 
until apparent steady state response was observed.  
In whole-cell recording, the parameter used to construct the concentration-
response curve was peak conductance, whereas in loose-seal cell-attached 
configuration we used the average firing rate over 1 or 3 minutes during steady 
state responses.  
In both cases, steady state values of different drug concentrations were normalized 
to control (usually the firing rate in the presence of phenylephrine) and used to 
construct concentration-response curves. 
The means of normalized measures were fitted with Prism 4 fitting facilities using 
a logistic equation: Y= bottom+ (top-bottom)/ 1+10ˆ((LogEC50-Log 
[Agonist])*Hill Slope)), to obtain estimate for EC50 and slope of the curve (Hill 
slope). 
Drugs 
(+)8-Hydroxy-N,N-dipropyl-2-aminotetralin, R-8-OH-DPAT, was prepared as a 1 
mM stock solution and diluted with distilled water to obtain intermediate stock 
solutions (a thousand times the experimental concentration), which were aliquoted 
and stored at -20 °C until use. All other drugs were prepared as stock solutions in 
distilled water, aliquoted and stored at -20 °C until use. All drugs were bath 
applied. When applied, organic receptor antagonists were perfused for 10 min 
before as well as during the agonist application. Agonists and inorganic salts were 
applied for ten or more minutes. N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]- 
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 N-(2-pyridyl)cyclohexanecarboxamide (WAY 100635, 50-100 nM), (+)8-
Hydroxy-N,N-dipropyl-2-aminotetralin (R-8-OH-DPAT, 1-300 nM),  5-
Carbossitryptamine (5-CT, 10-30 nM), were used as selective 5-HT1A receptor 
antagonist and agonists respectively. Phenylephrine was used as selective α1-
adrenergic agonist. L-tryptophan (Sigma) was used as precursor of endogenous 
serotonin. To block neurotransmission, we used a mixture of antagonists that 
collectively block most excitatory (glutamatergic) and inhibitory (GABA and 
glycine) fast synaptic responses: GABAA receptor antagonist SR-95531 (10 µM) , 
GABAB receptor antagonist 3-N[1-(S)-(3,4-dichlorophenyl)ethyl]amino-2-(S)-
hydroxypropyl-P-benzylphosphinic acid (CGP 55845 A, 2 µM), NMDA receptor 
antagonist D-2-amino-5-phosphonopentanoate (D-AP5, 20 µM), AMPA receptor 
antagonists 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM) or 6,7-
Dinitroquinoxaline-2,3-dione (DNQX, 10 µM) and the glycine receptor antagonist 
strychnine (10 µM). This mixture of drugs will be indicated as ”cocktail” of 
synaptic blockers throughout the following sections.  
Tetrodotoxin (TTX) was from Alomone (Jerusalem, Israel), all other drugs from 
Tocris Cockson (Bristol, UK) and Ascent scientific (Bristol, UK). 
Data were analysed using, Clampfit (Molecular Devices) and Prism 4 software 
(GraphPad Software, San Diego, CA, USA). Unless otherwise stated, data were 
expressed as the mean ± SD and were analysed statistically with the use of two-
tailed Wilcoxon or Mann–Whitney tests, as appropriate. A value of P < 0.05 was 
considered statistically significant. 
Statistical analysis 
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 Dye filling 
Fluorescent Dye intracellular labelling of the recorded cell and 
Immunohistochemistry 
In a subset of experiments, recording from putative serotonergic neurons were 
made using a pipette solutions containing either 2 mM Lucifer yellow (Sigma-
Aldrich) or Alexa Fluor 488 hydrazide, 300 µM (A10436 solid, Invitrogen). This 
allowed us to mark the recorded neuron with a high concentration of fluorescent 
dye, which facilitated subsequent post hoc identification of the recorded neuron. 
Following recording, the pipette was removed from the cell by pulling away and 
slowly lifting the pipette upward and, at the same time, trying to leave the soma 
intact. The formation of a giga-Ohm seal was observed. 
After the electrode removal, cell coordinates in respect to acqueduct midline and 
lower rim were recorded and the slices were cut on their right upper edge with the 
tip of an electrode to recognize the side containing the cell during the mounting 
process.  
Fixation 
The slices were washed with ACSF in a well to eliminate dye residues from tissue 
surface. Then they were fixed with 4% paraformaldehyde in phosphate buffer 
solution (PBS; 0.1 M) for 1–24 h.  
Immunohistochemical processing of slices was carried out in dim light and when 
the protocol did not require manipulation of the preparations, the well containing 
the slices was kept in a black box to avoid the exposure to light.  
Epitope retrieval method 
After fixation, the slices were rinsed three times in PBS 0.1 M. They were 
incubated, in eppendorf tubes, with sodium citrate buffer (10 mM sodium citrate, 
0,05% Tween 20, pH 6) and heated 3 min at 90°C, to retrieve the antigen's 
epitope.  
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 Aspecific antigens block 
To limit the binding of antibodies to aspecific sites these were “blocked” by 
adding goat serum to the incubating solution together with a nonionic surfactant to 
facilitate penetration of antibodies in brain tissue. Thus, slices were washed in 
PBS 0.1 M for 3 times and then incubated from 4 to 6 hours in a solution 
containing: 10% goat serum, 0.5% Triton X-100, 0.05% NaN3 in 0.1 M PBS.  
Incubation with antibodies 
To identify putative serotonergic neurons, fluorescent immunohistochemistry was 
performed by incubating slices overnight in the presence of a primary rabbit 
monoclonal antibody against L-tryptophan hydroxylase II (Gutknecht et al., 2008) 
diluted 1:900; in PBS 0.1 M with 0.05% NaN3, at 4°C. After washing with PBS 
0.1 M, slices were incubated overnight at 4°C with an antirabbit-Alexa Fluor 633-
conjugated secondary antibody (Molecular probes) diluted 1:500 in PBS 0.1 M 
with 0.05% NaN3. 
Sections mounting 
The sections were washed in PBS 0.1 M and in distilled water, then mounted on 
slides under microscopy to recognize the mark done for the correct orientation of 
the slice and recognition of recorded cell location. All excess of water was dried 
using a pipette and a narrow piece of paper tissue before a drop of gel-mounting 
medium for fluorescent specimens Vectashield (Vector Laboratories, Burlingame, 
CA) was put on the slide and the specimen coverslipped.  
The slide was gently pressed with forceps and the coverslip was sealed with nail 
varnish. Mounted sections were stored at -20 °C.  
Immunofluorescence visualization and image acquisition 
Immunofluorescence labelling was visualized using a Leica confocal microscope. 
Images were captured using a digital camera and Leica Confocal software 
(Version 2.5, Leica). When using the confocal microscopy, 79 sequential 
photomicrographs (0.5 µm tissue thickness each) were obtained by lowering focus 
on z axis relative to the x-y slice surface plane (z-series). This resulted in a 
tridimensional scanning for a total length of 51 µm. 37 images were acquired at 
68
 the level of the cell body of the labelled neuron through a total depth of 22 µm. 
Alexa 633 was revealed separately from Alexa 488. The laser power and emission 
filters were adjusted for both the red and green fluorophor so that there was 
negligible possibility of false positive result. This was done by exciting at the 
optimal wavelength for the green fluorophor and detecting using the emission 
spectra for the red fluorophor and vice versa. An Image as “projection” of all 
photomicrographs acquired was adjusted for optimal colour balance and contrast 
using Adobe Photoshop software. 
 
Tissue sampling and digestion 
Mice genotyping  
Mice at PND20-21 were divided from the mother and housed per gender. An ear 
tag was applied at each animal with the proper applicator. To obtain a sample of 
tissue for genotyping, the tip of the tail was excised (less than 0.5 mm) with a 
sterilized scalpel, on a surface cleaned with ethanol 70%, and inserted into a 
previously autoclave-sterilized eppendorf tube. For digestion, 200 µl of a buffer 
composed in mM: NaCl 20, pH 8-Tris HCl 50, pH8-EDTA 1, SDS 10% in 
distilled and sterilized water with 1 mg/ml proteinase K was added to each 
eppendorf tube and heated at 55°C for 4-5 h.  
DNA extraction 
After digestion, the samples were equilibrated adding to each 200 µl of 
phenolchloroform (4°C) and centrifuged 10 minutes at maximum rpm at 4°C to 
separate phases. Under a biological hood,  80 µl of the upper phase of each 
sample were removed and poured in a well of a flat-bottom 96-well plate, 160 µl 
of 100% ethanol (-20°C) was added in each well and the plate was leaved at RT at 
least 10 min without agitation. After this period the well was inverted gently but 
rapidly, onto a paper towel to remove the ethanol and wells were allowed to dry 
for 15 minutes under the hood. The DNA that would remain in the well was then 
resuspended in distilled (and sterilized) water.  
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 PCR cycling 
A PCR reaction was performed for each gene (Slc6a4tTA or Htr1atetO). For each 
sample 2 µl of DNA solution were mixed with 23 µl of PCR buffer composed by: 
Primer 1 or common primer (Sert-F1 or Htr1a tetO-F1) 2 µM, Primer 2 (Sert-R1 o 
Htr1a tetO-R1) 1 µM, Primer 3 (TTA-R1 or Htr1a tetO-R2) 1 µM (Sigma), native 
Taq polymerase 0.04 U/µl, dATP 0.2 mM, dCTP 0.2 mM, dGTP 0.2 mM, dTTp 
0.2 mM, KCl 50 mM, MgCl2 1.5 mM (Fermentas), bovine serum albumin 0.1 
mg/ml (Sigma), in distilled (sterilized) water. PCR cycling (see Table 1) was 
started with less than 5-10 min delay from the buffer mixing.  
Tab.1. PCR cycling protocol (GEN01) 
step time temperature action 
1 1:00 95°C  
2 0:15 95°C  
3 0:15 64°C  
4 1:30 72°C go to step 2, 2x 
5 0:15 95°C  
6 0:15 61°C  
7 1:30 72°C go to step 5, 2x 
8 0:15 95°C  
9 0:15 58°C  
10 1:30 72°C go to step 8, 20x 
11 0:15 95°C  
12 0:15 55°C  
13 1:30 72°C go to step 11, 10x 
14 10:00 72°C  
15 forever 10°C  
 
Alleles identification 
Once PCR was terminated 5 µl of running dye was added to each sample and 15 
µl of this mix were loaded on 2% agarose gel with ethidium bromide, 10 µl of 
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 100pb-1kb ladder was also loaded for reference. Identification bands for each 
allele were separated in gel electrophoresis after 1h at 110 V. Bands were 
visualized under an UV transilluminator. Slc6a4tTA gene: wt allele (Sert-F1/Sert-
R1) 306 pb, tta allele (Sert-F1/TTA-R1) 420 pb; Htr1atetO gene: wt allele (Htr1a 
tetO-F1/ Htr1a tetO-R2) 750 pb, tetO allele (Htr1a tetO-F1/ Htr1a tetO-R1) 338 
pb 
Tab.2. Primers sequences for both knock-in genes  
Gene Primer Name N-pb Primer sequence (5’ to 3’) 
Slc6a4tTA 1. Sert-F1 
19 GTC AGG GTC CTT GGC AGA T 
 2. Sert-R1 20 ATC TTC TTG CCC CAG GTC TC 
 3. TTA-R1 20 TCC AGG GTC TCG TAC TGC TT 
Htr1atetO 1. Htr1a tetO-F1 22 CAG TCT CTA GAT CCC CTC CCT T 
 2. Htr1a tetO-R1 22 AAG GGC AAA AGT GAG TAT GGT G 
 3. Htr1a tetO-R2 22 GGG CGT CCT CTT GTT CAC GTA G 
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 RESULTS 
 
The first main objective of our study was to evaluate the magnitude of the 
alteration in 5-HT1A receptor functioning produced by the mutations introduced in 
HTr1aRO mice and resulting in a selective overexpression of 5-HT1A receptors by 
serotonergic cells.  
Our first goal was therefore to quantitatively compare the response of HTr1aRO 
serotonergic cells with that of serotonergic cell, in wild-type mice. 
To afford this pharmacological investigation we decided to use loose-seal cell-
attached recording to estimate the concentration-response relationship of selective 
5-HT1A receptor agonists on firing rate of serotonergic neurons. In fact, this 
technique is minimally invasive and permits long-lasting recordings that are 
required to investigate the effects of multiple applications of drugs.  
Furthermore, the recorded parameters (action current/potential and neuron firing 
rate) reflect the activity of serotonergic neurons and would allow inference on the 
integrate effects of altered 5-HT1A receptor stimulation on serotonergic cell 
functioning. However, this technique does not allow to apply a series of 
electrophysiological protocols/tests that, with other recording configurations (e.g. 
whole-cell patch-clamp), could help to identify the recorded neuron type.  
On the other hand, to quantitatively compare the response of serotonergic cells in 
HTr1aRO and wild-type mice, unambiguous identification of the recorded cell type 
was required to avoid that results would be spoiled by the presence of non 
serotonergic cells in one of the two serotonergic neuron groups. 
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Identification of serotonergic neurons in wild-type and HTr1aRO mice 
Throughout the present work we used a “morpho-anatomical” criterion to select 
serotonergic cells before
Thus, to identify serotonergic from non serotonergic neurons we routinarily used 
the electrophysiological criterion developed in previous experiments on C57bl/6 
animals and based on the Up-to second Downstroke Interval (UD2I or UDI) 
parameter of action potential currents recorded in loose-seal cell-attached 
configuration. As detailed in methods, this parameter is strictly correlated with the 
shape and duration of the neuron action potential.  
 recording. Thus, we looked for neurons located in the 
midline of dorsal raphe region, where serotonergic cells are clustered and targeted 
cells that had larger diameter, because most of interneurons have a small soma. 
Therefore, non serotonergic neurons recorded in the present study were those that 
escaped the preliminary “morpho-anatomical selection”, and resulted to be a small 
group. Nevertheless, their presence induced to apply further criteria to confirm the 
nature of the recorded cell, namely electrophysiological properties and 
pharmacological responses to phenylephrine and/or selective 5-HT1A receptor 
agonists (see also methods).  
As illustrated in Fig 15A, by ordering all neurons recorded in wild-type mice on 
the basis of their measured UDI, the resulting distribution of cells made apparent 
that the small number of non serotonergic neurones could be clearly discriminated 
from serotonergic neurons for their UDI < 0.9 ms. 
Unexpectedly, when we applied the same electrophysiological criterion during 
recording from HTr1aRO mouse neurons displaying typical serotonergic action 
current waveform and firing behaviour, we realised that the duration of their 
action currents was shorter than usual.  
As illustrated in Fig 15B, the distribution analysis carried out on neurones 
recorded from dorsal raphe of HTr1aRO mice made apparent that the histogram 
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 was skewed towards the left  (i.e. towards lower UDI values) for the whole 
population of recorded cells.  
A more attentive analysis shows that twelve cells of HTr1aRO mice displayed an 
UDI with a range of 0.9-1.1 ms, rarely seen in otherwise unequivocally 
recognizable serotonergic neurons of wild-type and C57bl/6 mice. For example, in 
our experiments on wild-type, only one serotonergic cell is found in this range 
(see Fig. 15A).  
It seemed reasonable to assume that these cells were also serotonergic as their 
UDI was >0.9 ms, and had typical serotonergic waveform and firing behaviour. 
Nevertheless, when we became aware of this phenomenon, we tested a sample of 
the cells displaying a UDI comprised between 0.9 and 1.1 ms for their response to 
the application of selective 5-HT1A receptor agonists (R-8-OH-DPAT or 5-CT 3-
10 nM), that is the second best choice between criteria to identify serotonergic 
cells. 
All six cells tested were silenced by the application of R-8-OH-DPAT or 5-CT 10 
nM, thus we concluded with a high degree of confidence that the others were also 
serotonergic. On the other hand, it should be noted that some of neurons 
displaying an UDI shorter than 0.9 ms could also have been serotonergic.  
Investigating this issue resulted unpractical in terms of effectiveness regarding the 
main project and therefore we adopted the established criterion of an UDI shorter 
than 0.9 ms to discriminate non serotonergic neurons, although it remains possible 
that a small number of serotonergic neurons resulted excluded. 
On the other hand, we became concerned of the possibility that serotonergic cells 
of HTr1aRO mice underwent adaptive changes in their intrinsic cell membrane 
properties, which could affect the response to serotonin. Therefore, we compared 
several electrophysiological parameters of serotonergic cells recorded from 
HTr1aRO  
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Fig. 15. Distribution histograms of the distinctive parameter Up-to Downstroke 
Interval (UD2I) in wild-type (WT) and HTr1aRO mice (RO). Interneurons are clearly 
separated by this parameter from serotonergic cells in wild-type mice. 
Serotonergic cells (red) were found with UDI value > 1.1 ms, interneurons (grey) 
with UDI  < 0.9 ms. Note that in wild-type mice (A) only one serotonergic cell out 
of 95 had an UDI comprised in the “boundary interval” between 0.9 and 1.1 ms. 
In HTr1aRO mice (B) the number of putative serotonergic cells found in the 
“boundary” range 0.9-1.1 ms increased to 12 out of 84, 6 of which were 
confirmed to be serotonergic using additional criteria (see text). 
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 and wild-type mice to reveal possible alterations in basic intrinsic cell membrane 
properties of serotonergic cells in the mutant mice. 
 
 
Electrophysiological properties of serotonergic neurons  
First, we assessed whether the UDI parameter, that seemed systematically shorter 
in HTr1aRO mice than in wild-type animals, was statistically different in the two 
mouse strains. As shown in Fig. 16, the Up-to second Downstroke Interval was 
indeed significantly shorter in HTr1aRO mice (1.42 ± 0.40 ms, n=84) compared 
with that of wild-type animals (1.67 ± 0.43 ms, n=95, P value < 0.001, Mann 
Whitney test).  
Since UDI of action currents corresponds to action potential half-height width 
(HHW, see methods), these results show that action potential duration of 
serotonergic cells in HTr1aROmice was also shorter than that of serotonergic cells 
in wild-type mice. 
We examined for differences in serotonergic cells basic properties also whole cell 
experiments. However since they were performed to investigate 5-HT1A receptor 
activated GIRK-current, properties like resting membrane voltage, input 
resistance and action potential half-height width resulted modified by the special 
experimental conditions used. The only exception was total membrane 
capacitance that is independent by such manipulations (Fig. 16). Membrane 
capacitance was then found significantly smaller in serotonergic cells of HTr1aRO 
mice (35.67 ± 6.73 pF, n=20) compared with that of wild-type (40.44 ± 7.67 pF, 
n=38, P value < 0.05, Mann Whitney test). 
These results also strongly indicated that there were differences in 
electrophysiological or basic properties between serotonergic cells of wild-type 
and HTr1aRO mice. We further investigated this issue using loose-seal cell-
attached  
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Fig. 16. The Up-to second Downstroke Interval and Cell capacitance are smaller 
in HTr1aRO than in wild-type mice. (A) Bar graph shows the mean (± SD) values 
of UDI parameter for serotonergic neurons in wild-type (WT, n=95) and HTr1aRO 
mice (RO, n=84) and. Asterisks indicate highly significant difference (P=0.0003, 
Mann Whitney test). (B) Bar graph shows the mean (± SD) values of cell 
membrane capacitance for serotonergic neurons in wild-type (WT, n=38) and 
HTr1aRO mice (RO, n=20) and. Asterisks indicate a significant difference with P 
value < 0.05. 
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 recording to obtain information on firing behaviour of neurons with recording 
conditions that produced minimal perturbation of neuron properties.  
The first electrophysiological property we investigated was the firing rate of 
serotonergic neurons. Firing rate was measured i) as the spontaneous firing rate in 
conditions in which serotonergic neurons were pharmacologically isolated from 
major excitatory and inhibitory inputs, and ii) as the maximum firing rate of 
neurons during their maximal activation by stimulation of α1-adrenoceptors, that 
is in conditions similar to those of waking state in vivo. 
The intrinsic spontaneous firing rate was measured as the number of action 
currents on 1-3 minutes of recording at steady-state superfusion of antagonists for 
fast and slow synaptic transmission, to isolate the cells from network activity.  
The mean intrinsic firing rate was similar in serotonergic cells of wild-type (0.636 
± 0.856 Hz, n = 49 ) and HTr1aRO (0.497 ± 0.792 Hz ,n = 27) mice, (Fig. 17, left). 
As can be noted the intrinsic firing rate variability was very high. It was ranging 
from 0-4 Hz in both cells of the two mice strains, but most of them were silent in 
both groups, 59.2 % for wild-type, 66.7% of total cells for HTr1aRO mice, (29/49 
and of 18/27 respectively). The maximum serotonergic firing rate or “waking 
state”-related firing rate, was evoked by application of the α1-adrenoreceptor 
agonist phenylephrine and measured as the number of action currents in 1 minute 
of recording at maximum drug effect. The mean evoked firing rate was also 
similar, for serotonergic cells of wild-type (2.094 ± 1.058 Hz, n=69) and HTr1aRO 
(1.906 ± 1.143 Hz, n=56) mice (Fig. 17, right.).   
The magnitude of response to the α1-adrenoceptor agonist phenylephrine was also 
evaluated. The change in firing frequency of serotonergic cells, relative to their 
basal firing rate, elicited by phenylephrine was found to be quite similar in 
serotonergic neurons of wild-type and HTr1aRO mice, i.e. 1.615 ± 0.906 Hz (n = 
40) and 1.409 ± 0.732 Hz (n=27) increase, respectively (Fig. 18).  
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Fig. 17. Firing rate activity of serotonergic neurons in wild-type (WT) and HTr1aRO 
mice (RO) is not significantly different. Left, the scatter plot shows the 
spontaneous firing rate in serotonergic cells isolated from network activity by the 
presence of glutamate AMPA and NMDA receptor antagonists and of GABAA, 
GABAB, and glycine receptor blockers (see methods for details on this “cocktail” 
of antagonists). Under these conditions, firing rate is not significantly different 
between serotonergic cells of the two strains of mice (n = 49 WT; n=27 RO; Mann 
Whitney test, P=0.285). It can be noted that the most of cells are silent in both 
groups with the same proportion. Right, scatter plot of firing rate in the presence 
of the α1-adrenoceptor agonist phenylephrine (PhEP, 10 µM, to reproduce the 
typical activation of serotonergic cells during waking state in vivo). In serotonergic 
cells of both mice strains the firing rate in phenylephrine is not significantly 
different (n=69 WT, n=56 RO; Mann Whitney test, P=0.133). Note that the two 
populations have quite the same variability.  
 
 
 
 
 
79
 From this initial set of experiments we concluded that, the decrease in duration of 
action potential made apart, serotonergic neurons in HTr1aRO mice seemed to 
behave as “normal” serotonergic neurons in respect of their firing frequency and 
sensitivity to α1-adrenoceptor activation by phenylephrine. We therefore 
considered that the response to 5-HT1A receptor agonist could be investigated in 
HTr1aRO mice serotonergic neurons without the risk of a systematic bias 
introduced by an alteration in firing properties of these cells. 
 
Serotonergic neurons of HTr1aRO mice are known to express ~10 times higher 
density of 5-HT1A receptors compared to those of wild-type (Audero et al., 2008), 
but the direct proof that these newly (over)expressed receptors were able to 
respond to their direct activation by 5-HT1A receptor agonists was still missing.  
Responses of serotonergic neurons to the selective 5-HT1A receptor agonist R-
8-OH-DPAT 
To quantify the level of functionality of these receptors in DRN serotonergic 
neurons of HTr1aRO mice we measured the response of serotonergic cells to 
5-HT1A receptor activation by the selective 5-HT1A receptor agonist R-8-OH-
DPAT on a set of electrophysiological parameters.  
R-8-OH-DPAT is a potent 5-HT1A agonists with high affinity and selectivity 
(>400-folds) for 5-HT1A receptors relative to other 5-HT binding sites (5-HT1B 
,1C,1D, 5-HT2, or 5-HT3) (Van Wijngaarden et al., 1990). In serotonergic cells, 
activation of 5-HT1A receptors by R-8-OH-DPAT is known to open G protein-
coupled inwardly rectifying potassium channels (GIRK) and to hyperpolarize the 
neuron, thereby decreasing neuron firing rate. 
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Fig. 18. Magnitude of the response of serotonergic cells to application of 
phenylephrine (PhEP, 10 µM) in wild-type (WT) and HTr1aRO mice (RO). The 
change in firing rate induced by PhEP in both groups of serotonergic cells is not 
significantly different (P=0.516, Mann Whitney test), but the high variability of 
individual responses in both groups was very high. 
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 Effect of R-8-OH DPAT on serotonergic neuron firing rate 
In a first set of experiments, we quantified the response to R-8-OH-DPAT on 
firing rate using loose-seal cell-attached voltage-clamp recording.  
All experiments were carried out in the presence of a “cocktail” of glutamate, 
GABA and glycine receptor antagonists to block fast and slow synaptic 
transmission. Under these conditions serotonergic cells were isolated from 
network activity intrinsic of raphe nuclei. 
Thus, the effect of 5-HT1A receptor stimulation on serotonergic neuronal firing 
rate could be studied in isolation from indirect mechanisms, induced by the action 
of the agonist on other raphe cells (e.g. GABAergic interneurons).  
To reinstate in vitro the maximal noradrenergic drive of serotonergic neuron firing 
present during waking in vivo, phenylephrine (10 µM) was added to the 
superfusing fluid at least five minutes before application of R-8-OH-DPAT 
perfusion.  
As shown in Fig. 19, the agonist R-8-OH-DPAT induced a concentration-
dependent inhibition of serotonergic neuronal firing in both wild-type and 
HTr1aRO mice. This effect was reversible upon washout of the agonist (not shown 
for HTr1aRO mice). Using a similar protocol we collected data for assessment of 
concentration-response relationships in wild-type and HTr1aRO mice. This 
allowed a comparison of R-8-OH-DPAT effectiveness in decreasing the neuron 
firing rate in HTr1aRO compared to wild-type mice. 
Firing rate values for the construction of concentration- response curves were 
measured as the number of action potential on 1-3 minutes of recording at the end 
of perfusion-time (10 min) for each R-8-OH-DPAT concentration. These firing 
rate values were normalized to control firing rate in phenylephrine for each 
recorded neuron. The averages of the normalized firing response elicited by 
different concentration of R-8-OH-DPAT in serotonergic neurons from both wild-
type and HTr1aRO were then used and fitted by a logistic equation (see methods) 
to graph the  
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Fig. 19. Concentration-dependent inhibition of serotonergic firing rate induced by 
the selective 5-HT1A receptor agonist R-8-OH-DPAT in wild-type and HTr1aRO 
mice. Graphs show time-course of firing frequency (expressed as number of 
action potential over 10 seconds) recorded from serotonergic cells with loose-
seal cell-attached patch configuration in typical experiments. Upper panel: in a 
serotonergic cell from a wild-type (WT) mouse, phenylephrine (PhEP, 10 µM) 
increases the firing rate of the neuron. Addition of  R-8-OH-DPAT concentration-
dependently decreased neuron firing rate. The effect of R-8-OH-DPAT is 
completely reversible and pre-drug firing rate is recovered within ~ 15 min after 
agonist removal from superfusion ACSF. Lower panel shows a similar experiment 
performed on a serotonergic cell of a HTr1aRO (RO) mouse. Note that the 
experiment already started in the presence of phenylephrine. After perfusion of 
high concentration of R-8-OH-DPAT, barium was applied to avoid the need for 
long washout period. Barium at a concentration (150 μM) that preferentially 
blocks GIRK channels including these activated by 5-HT1A receptors, produced 
full recovery of firing rate, indirectly confirming that the decrease of firing is 
mediated by this receptor. 
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 concentration-response curves (Fig. 20) and obtain an estimate for their EC50 and 
slope. 
As illustrated in Fig. 20, the concentration-response curve for R-8-OH-DPAT 
obtained from HTr1aRO mouse serotonergic cells was placed to the left of that 
from serotonergic neurones in wild-type mice, indicating greater effectiveness of 
R-8-OH-DPAT in HTr1aRO mice. 
Thus, in wild-type serotonergic cells the EC50 value was 3.569 nM and the curve 
Hill-slope was equal to -1.7, (n=12). For HTr1aRO serotonergic neurones, the EC50 
value was 1.585 nM and the curve Hill-slope was equal to -1.5, (n=11). The 95% 
confidence intervals of EC50 for the two fits were significantly different (3.13 to 
4.06 nM for wild-type; 1.10 to 2.29 nM for HTr1aRO mice) as well as the Hill 
slopes (-2.036 to -1.338 for wild-type; -2.215 to -0.750 for HTr1aRO mice). 
Fig. 20 also reports the comparison of the magnitude of responses elicited by 3 
nM R-OH-DPAT in serotonergic cells from HTr1aRO mice and wild-type mice. 
The scatter plot shows that the 5-HT1A receptor agonist elicited significantly 
greater responses in HTr1aRO compared to wild-type mice (P<0.05; Mann 
Whitney test).  
Thus, our data show that the firing of serotonergic neurons of mutant mice was 
more sensitive to agonist-mediated 5-HT1A receptor stimulation than that of wild-
type mice.  
Nevertheless, it must be noted that the sensitivity of HTr1aRO serotonergic 
neurons to 5-HT1A receptor activation was less than what expected from a ten 
times 5-HT1A receptor overexpression in these cells. 
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Fig. 20. Dorsal raphe serotonergic neurons of HTr1aRO mice are more sensitive to 
5-HT1A receptor activation than those of wild-type mice. Concentration-response 
relationship for R-8-OH-DPAT on firing rate of serotonergic neurons in wild-type 
(WT) and HTr1aRO (RO) mice. The firing rate in R-8-OH-DPAT is normalized to firing 
rate in phenylephrine (see text). Right panel shows the effect of 3 nM R-8-OH-DPAT 
concentration on firing rate. Mean firing rates in 3 nM R-8-OH-DPAT are significantly 
different (asterisk: P=0.0423, Mann Whitney test) in the two mouse groups. Note the 
high variability in response of WT animals compared to RO mice. 
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 Effect of R-8-OH DPAT on barium-sensitive inwardly-rectifying K+ conductance 
A precise measure of 5-HT1A receptor-mediated effects cannot be performed in 
loose-seal cell-attached experiments as in this configuration only the firing rate is 
monitored, and no direct information can be obtained on the extent of membrane 
hyperpolarization that follows 5-HT1A receptor stimulation in serotonergic 
neurons. 
To further investigate 5-HT1A receptor- mediated inhibition of serotonergic cells 
we extended our study using whole-cell voltage-clamp, which allowed to directly 
measure the extent of GIRK channel activation in the two strains of mice.  
Indeed, whole-cell voltage-clamp recording permits to monitor the change of the 
5-HT1A sensitive GIRK current, thus provides a more precise evaluation of half-
maximal effect (EC50) and of the maximal response to the activation of 5-HT1A 
receptors.  
The GIRK channel current activation elicited by R-8-OH-DPAT is identified as an 
inward rectification of the total current measured in a voltage range between -60 
and -120 mV. 
Although R-8-OH-DPAT is generally effective in external solutions containing 
2.75 mM K+, higher potassium concentrations in the ACSF enhance the 
rectification induced by R-8-OH-DPAT (i.e. GIRK opening) allowing for more 
precise quantification of the effects produced by 5-HT1A receptor activation. 
Therefore all voltage-clamp recordings were carried out in the presence of higher 
extracellular K+ concentration (5.5 mM). In addition, we applied TTX (1 µM) to 
block sodium voltage-activated channels and synaptic transmission. 
Hyperpolarizing ramp voltage commands from a holding potential of -60 to -120 
mV were used to characterize the I-V relationships of serotonergic raphe neurons 
before, during, and after exposures to R-8-OH-DPAT.  
Figures 21 and 22 show traces and analyses of a typical experiment to illustrate 
how data were gathered and values for statistical comparison obtained. 
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Fig. 21. Typical whole-cell voltage-clamp recording of conductance changes 
produced by R-8-OH-DPAT in a serotonergic neuron. (A) Time-course course of 
the slope conductance response to R-8-OH-DPAT application. Total cell 
membrane current elicited every 10 s by hyperpolarizing ramps through the 
recording pipette (B, C) to monitor the effects of increasing concentrations of R-8-
OH-DPAT applied using a cumulative protocol. The effect was measured as 
slope conductance (see Fig. 22A). (B) illustrates the voltage ramp protocol 
applied to the neuron and (C) shows superimposed traces of the current evoked 
by the ramp in control and in the presence of increasing concentrations of R-8-
OH-DPAT (1-300 nM), followed by application of barium (0.15 mM). In (A) note 
the slight reduction of conductance in 300 nM R-8-OH-DPAT (R8HD), probably 
due to receptor desensitization and the rapid recovery of conductance to control 
values in the presence of barium that blocks GIRK channels. Each trace in (C) is 
the average of five responses recorded in control and at steady-state drug effect 
for each drug application.  
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Fig. 22. Concentration-dependent activation of 5-HT1A sensitive potassium 
conductance by R-8-OH-DPAT and the relative inwardly rectifier current in a 
typical whole-cell voltage-clamp experiment. Same cell as in figure 21). (A) panel, 
shows the current voltage relationship of 5-HT1A sensitive channels activated by 
R-8-OH-DPAT (concentrations in nM are indicated). Note the progressive 
increase in inward rectification with the increasing magnitude of current evoked 
by higher concentration of R-8-OH-DPAT. The linear regression fit to obtain the 
slope conductance is shown as a black line on each averaged traces. The (B) 
panel shows the concentration-response curve for slope conductance obtained 
as above. Note that the point at 300 nM was excluded for fit as desensitization 
occurred. 
A 
B 
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 The current induced by R-8-OH-DPAT (Fig. 21B, 22A) displayed the 
characteristics of inwardly rectifying GIRK current activated by serotonin as 
described also for other preparations (Pan et al. 1990,1993; Penington et al. 
1993a; Williams et al. 1988, Bayliss et al. 1997).  
A distinctive feature of the 5-HT1A receptor-activated inwardly rectifying K+ 
current is the sensitivity to low concentrations of barium (Pan et al. 1990, 1993; 
Penington et al. 1993a; Williams et al. 1988). Thus, at the end of experiments we 
applied barium (0.15 mM) to further confirm the nature of current evoked by R-8-
OH-DPAT. 
To quantitate the effects of R-8-OH-DPAT on conductance, the I-V relationship 
between – 85 and -100 mV (Fig. 22A) was fitted by linear regression and the 
slope taken as the equivalent of conductance (slope conductance). 
In Fig. 21A the slope conductance is plotted over time to show the time-course 
and the magnitude of the changes in conductance produced by application of 
increasing concentrations of R-8-OH-DPAT, using a “cumulative protocol”. 
Superfusion of R-8-OH-DPAT (1-300 nM) induced a concentration-dependent 
increase in slope conductance that fully recovered with the perfusion of barium 
0.15 mM.  
For the construction of concentration response curves, the slope conductance was 
calculated on I/V relationship obtained from the average of 5 traces taken at the 
end of R-8-OH-DPAT application for each concentration (Fig. 22A). The values 
collected were fitted by a logistic equation (see methods) to graph the 
concentration-response curves and obtain an estimate for their EC50 and slope 
(Fig. 22B). 
The mean of EC50 values for wild-type was 15.61 nM with a 95% confidence 
interval from 3.65 to 27.56 nM, (n=9). The mean of EC50 values for HTr1aRO was 
7.79 nM with a 95% confidence interval from 3.69 to 11.88 nM (n=7). When 
compared, the EC50 values for conductance, obtained for serotonergic cells, were 
not significantly different in HTr1aRO and wild-type mice (Fig. 23).  
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Fig. 23. Comparison between Log EC50 values of R-8-OH-DPAT (R8HD) for 
increase in 5-HT1A sensitive potassium conductance in serotonergic cells of wild-
type (WT) and Htr1aRO(RO). Groups are not significantly different (P=0.407, 
Mann Whitney test). 
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 We used the same experiments to evaluate the maximal 5-HT1A sensitive 
potassium conductance activated by R-8-OH-DPAT. Total 5-HT1A receptor 
sensitive potassium conductance was evaluated subtracting the residual 
conductance in the presence of barium, which in our condition blocked mostly the 
activated GIRK channel, from maximal conductance evoked by R-8-OH-DPAT 
(Fig. 24 A and B).  
We found that the total 5-HT1A sensitive potassium conductance in serotonergic 
cells was 8.654 ± 1.899 nS in wild-type (n=9), and 8.034 ± 1.350 nS in HTr1aRO 
mice (n=7), that were not significantly different (P=0.536, Mann Whitney test). 
The fraction of 5-HT1A sensitive potassium conductance active in basal conditions 
in serotonergic cells of HTr1aRO and wild-type mice was also evaluated. 5-HT1A 
sensitive potassium conductance active in basal conditions was defined as basal 
conductance minus the residual conductance in barium and its fraction is 
calculated on total 5-HT1A sensitive potassium conductance, defined above.  
A fraction of 5-HT1A sensitive potassium conductance is active in basal condition 
both in wild-type, 4.861 ± 6.562 % of total (significantly different from residual in 
barium, P=0.0117, Wilcoxon test), and in HTr1aRO mice 21.39 ± 6.973 % of total 
(P=0.0156, Wilcoxon test). As shown in Fig. 24D, the fraction of 5-HT1A sensitive 
potassium conductance active in basal conditions in HTr1aRO mice was 
significantly different from that in wild-type (P=0.0021, Mann-Whitney test).  
This last finding indicates that a fraction of the total 5-HT1A sensitive GIRK 
channels is already open in basal conditions and that this fraction is greater in 
HTr1aRO in comparison to wild-type serotonergic cells.  
To confirm if a greater fraction of “GIRK like” basal conductance is present in 
HTr1aRO serotonergic cells also in conditions which in vitro mimic the activation 
of these neurons in vivo and/or it can affect the firing rate of HTr1aRO serotonergic 
neurons at rest, we performed additional tests in loose-seal cell-attached 
recording.  
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Fig. 24. Basal 5-HT1A sensitive potassium conductance and total evoked by R-8-
OH-DPAT in serotonergic cells of wild-type and HTr1aRO mice. In (A) wild-type 
single cell, the current in control (Ctrl), in maximal concentration of R-8-OH-DPAT 
(R8HD) and the residual current in barium; on each trace the linear regression 
interval used to obtain the respective slope conductance value is shown in red. 
Right, the net currents obtained from subtraction of current in barium from that in 
control (basal 5-HT1A sensitive ) and from current in the presence of maximal 
concentration of R8HD (total 5-HT1A sensitive). In (B) the same for HTr1aRO 
mice; the greater basal activated current can be noted. (C) comparation in wild-
type and HTr1aRO mice between total 5-HT1A sensitive potassium conductance 
(see text) and (D) the comparation of the fractional 5-HT1A  sensitive potassium 
conductance active in basal condition (significantly different  (P=0.0021, Mann-
Whitney test,).  
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 Effects of barium on serotonergic neuronal firing rate 
We tested few cells in both mice for the presence of a “GIRK like” basal 
conductance in basal conditions. Barium was chosen to evaluate the level of 
GIRK channel activation, presumably mediated by 5-HT1A receptors, because it 
directly and rapidly blocks the channels, its effect is easily reversible upon ion 
washout and low concentrations are needed to block all GIRK channels. To mimic 
in vivo condition in brain slices, phenylephrine was added to ensure the maximal 
activation of serotonergic cells, characteristic of waking state. 
In a typical test, control baseline firing rate was monitored for 10 minutes; barium 
was applied for 5 minutes and then washed out for 10 minutes. The firing rate in 
control, in barium and washout was measured as number of action potential on 1-
3 minutes at steady state. In some experiments R-8-OH-DPAT (30 nM) and/or the 
selective 5-HT1A receptor antagonist WAY 100635 (50 nM) were applied to 
confirm the nature of recorded cells and the presence of 5-HT1A receptor basal 
activation (data not shown).  
Barium increased the firing rate of all cell tested (n=3) in HTr1aRO mice as shown 
for example in the Fig. 25. and in wild type animals (n=3). 
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Fig. 25. Effect of barium on serotonergic firing rate in HTr1aRO mice (RO). 
Timecourse of instantaneous frequency of a HTr1aRO serotonergic cell shows the 
rapid and revesible increase in firing rate induced by barium (Ba2+) 150 μM. 
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Regulation of serotonergic neuron activity in mice overexpressing 5-HT1A 
autoreceptors (Htr1aRO mice). 
5-HT1A receptor-mediated autoinhibition of serotonergic neurone firing: 
response to the serotonin precursor L-tryptophan 
 
As the physiological function of 5-HT1A receptors expressed on serotonergic 
neurons is to mediate the autoinhibition of their firing activity, we quantified the 
magnitude of this process in wild-type and HTr1aRO mice.  
In this context, it is worth mentioning that serotonin content in slices results 
lowered by damage caused by the slicing procedure and by the poor endogenous 
availability of L-tryptophan, which is the aminoacidic precursor of serotonin and 
that cannot be produced by animal cells. Previous studies demonstrated that 
supplementation of ACSF with L-tryptophan, restored the physiological content 
of endogenous 5-HT in slices (Mlinar et al., 2005; Liu et al., 2005). Therefore, 
addition of L-tryptophan to ACSF would reconduct synthesis of serotonin to 
normal level, would avoid further depletion of the neurotransmitter following 
pharmacological activation of serotonergic cells (Mlinar et al. 2005) and would 
re-establish a “physiological” level of serotonin in the extracellular space 
surrounding serotonergic cells. 
Under these conditions one would also expect that the newly synthesised 
serotonin, released by serotonergic cells, would activate 5-HT1A receptors 
expressed on the somatodendritic region of serotonergic neurons and thereby 
(auto) inhibit their firing activity.  
In fact, superfusion of L-tryptophan rapidly (~10 min to reach steady-state 
response) reduces serotonergic neuron activity and this effect is completely 
reversed by the 5-HT1A receptor  antagonist WAY100635 (50 nM), demonstrating 
that the L-tryptophan-induced inhibitory response is mediated by 5-HT1A receptor 
activation (Mlinar et al., 2005; Liu et al., 2005) see Fig. 26.  
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 Collectively, these findings show that the autoinhibition mediated by 5-HT1A 
receptors can be restored in slices by the perfusion of L-tryptophan. 
On the other hand, assuming that the synthesis of serotonin, hence its release and 
extracellular level, would directly depend on the extracellular concentration of the 
precursor L-tryptophan, it can expected that the degree of autoinhibition produced 
by a given concentration of L-tryptophan in ACSF would strictly depend on the 
number of 5-HT1A receptors expressed by serotonergic cells.  
Thus, to evaluate the level of autoinhibition in serotonergic cells overexpressing 
5-HT1A receptors compared to that present in serotonergic neurons with normal 
expression of these receptors, we measured the change in firing rate of 
serotonergic neurons induced by different concentrations of L-tryptophan, using 
loose-seal cell-attached voltage-clamp recording.  
To study the effect of L-tryptophan on dorsal raphe serotonergic cells isolated 
from network we added a “cocktail” of antagonists to ACSF, so to block fast and 
slow excitatory and inhibitory synaptic transmission (see methods). Phenylephrine 
(10 µM) was added to the bath previously to the L-tryptophan perfusion, (i.e. 5 
minutes) to reproduce the maximal noradrenergic drive present during waking in 
vivo.  
In a typical experiment, L-tryptophan was applied after collection of a stable 
neuron firing rate in phenylephrine for 10-20 minutes, to ensure a stable baseline 
reference for calculating the autoinhibition of neuron activity produced by L-
tryptophan. 
L-tryptophan was applied for 10-15 minutes for each concentration, and then 
washed out for 10 min. In some experiments, barium was applied to confirm that 
L-tryptophan-mediated response was induced by the activation of GIRK channels 
(Fig. 26). In all HTr1aRO serotonergic cells tested (n=4), L-tryptophan produced a 
concentration-dependent decrease of neuron firing and a complete inhibition with 
30 µM, while in wild-type neurons little, if any, decrease of firing was observed in 
all cases (n=5). Typical examples are illustrated in Fig. 26.  
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 The firing rate values for the construction of concentration response curve were 
measured at the end of perfusion-time (10-15 min) for each L-tryptophan 
concentration as the number of action potential on 1-3 minutes of recording. 
These firing rate values were normalized to control firing rate in phenylephrine. 
The averages of the normalized firing response elicited by different concentration 
of L-tryptophan for both wild-type and HTr1aRO serotonergic neurons were fitted 
by a logistic equation, to obtain estimate for the maximal effect on firing. The 
maximal effect for wild-type is 0.88 ± 0.05 respect to control, in other words there 
is only 12 % decrease in firing rate from that in phenylephrine, with the maximal 
concentration of L-tryptophan (30 µM). In HTr1aRO mice instead, the maximal 
effect is 0.07 ± 0.16 or a 93 % reduction in firing rate from that of control in 
phenyleprine. To exclude that the effect of L-tryptophan on HTr1aRO cells was 
due to lack of functionality of serotonin transporter (see in methods, HTr1aRO 
mice production and characteristics), we performed the same experiment on 
HTr1aRO mice fed with doxycycline (DOX, n=3) (Fig. 27). This drug prevented 
the overexpression of 5-HT1A receptors and let the possible effects due to the Sert 
null-allele be unmasked. No differences between concentration response curve of 
L-tryptophan in DOX-treated HTr1aRO mice and wild-type were seen, confirming 
that the different effect of L-tryptophan in HTr1aRO mice is linked to the 5-HT1A 
overexpression. 
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Fig. 26. Concentration-dependent (auto)inhibition of firing rate induced by 
serotonin precursor L-tryptophan in wild-type (WT, upper panel) and HTr1aRO 
mice (RO, lower panel). Time-course of the effect produced by increasing 
concentrations of tryptophan added to ACSF to produce concentration response 
curves with a cumulative protocol. Arrows indicate the beginning of phenylephrine 
(PhEP) application (10 µM, kept constant thereafter). Note that phenylephrine-
induced increase in firing rate slightly fades after an initial peak and stabilizes 
within 5 min from beginning of application. Baseline for calculating the effect of L-
tryptophan applications is taken in the following 5-10 minutes of steady-state 
response.  
 
Upper panel: typical experiment in a serotonergic neuron from a wild-type mouse 
showing that in normal mice L-tryptophan evokes little, if any, inhibition of firing 
rate. Lower panel: in a serotonergic cell of a HTr1aRO mouse firing is silenced by 
30 µM L-tryptophan. In this cell, the full recovery of firing rate during barium 
application (150 μM) confirmed that the decrease in firing induced by L-
tryptophan, was mediated by GIRK channels. 
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Fig. 27. Concentration-response relationship of L-tryptophan on firing rate of 
serotonergic neurons in wild-type (WT), HTr1aRO (RO), and Doxycycline fed-
HTr1aRO mice (DOX). The firing rate in L-tryptophan is normalized to firing rate in 
phenylephrine, (see text).  
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CO2/pH chemosensivity of serotonergic neurons in 5-HT1A raphe 
overexpressing (Htr1aRO) mice. 
Responses of serotonergic neurons to changes in extracellular CO2/H+ 
concentration. 
 
Serotonergic neurons have been shown to be sensors of carbon dioxide and pH. 
They respond to hypercapnic acidosis with an increase in activity in vitro 
(Richerson, 1995; Wang et al., 2001), and in vivo (Larnicol et al., 1994; Veasey et 
al., 1995; Haxhiu et al., 2001; Johnson et al., 2005), and this causes an increase in 
5-HT release in vivo (Kanamaru and Homma, 2007).  
There is also evidence that medullary serotonergic neurons can act as 
chemoreceptors and stimulate breathing during hypercapnic ventilator response 
(HCVR) either by increasing the gain of respiratory neurons or by enhancing the 
activity of nonserotonergic chemoreceptors (Putnam et al., 2004; Li et al., 2006; 
Mulkey et al., 2007).  
Chemosensitive serotonergic neurons in the midbrain are believed to mediate non-
respiratory responses to hypercapnic acidosis that might be just as important for 
survival as increased ventilation, such as arousal from sleep (Berry et al., 1997), 
an intense feeling of anxiety (Klein et al., 1993) and changes in cerebrovascular 
tone (Madden et al., 1993).  
A developmental defect in carbon dioxide chemoreception has been proposed to 
have a role in the etiology of SIDS (Richerson et al., 2004), syndrome that is 
known to be linked to serotonergic system deficits.  
In the present work we were studying the serotonergic cell activity of a mouse 
that, in addition to higher level of autoinhibition, shows severe and often mortal 
autonomic dysregulation that resemble the events of SIDS. Therefore we asked 
whether 5-HT1A receptor overexpression could cause a change in serotonergic 
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 neuron homeostatic properties, like CO2/pH sensitivity, suggesting a possible 
explanation for the SIDS-like autonomic deficits in these mice.  
To inquire this issue, we devised to assess if HTr1aRO and wild-type mice display 
different responses to CO2/pH challenge.  
The experiments were carried out in loose seal voltage-clamp recording to 
minimally perturb the spontaneous activity of the cells. Slices were initially 
perfused with a “cocktail” of antagonists to block synaptic neurotransmission such 
to isolate the single cells activity from network. Phenylephrine (10 µM) was 
routinarily added to ACSF to reproduce the maximal noradrenergic drive present 
during waking in vivo. 
In a typical experiment 10-20 minutes of firing rate in phenylephrine were 
recorded before perfusion of ACSF with 9 % or 3 % CO2  to have a stable baseline 
(Fig. 28). Serotonergic neurons were exposed to an increase in CO2 to 9 % or a 
decrease to 3 % at constant NaHCO3 concentration for 15-20 min, resulting in a 
change in pH from 7.4 to 7.18 or 7.63 respectively. Then, slices were left to 
recovery normal activity for at least 15 min with an ACSF with CO2 5 % (normal) 
following each application with ACSF at different fraction of CO2.  
In some cells two successive and alternate application of ACSF with 9 % and 3% 
CO2 were done to further confirm serotonergic neuron chemosensitivity (Fig. 28) 
The firing rate in control, in the presence of ACSF with 9-3 % CO2 and washout 
was measured as number of action potential on 3 minutes at steady state. The 
effect of CO2 change was expressed as percent change of firing from baseline, 
taking as “baseline” firing rate the mean between firing rate in control and the 
relative washout for each different application.  
In wild-type, serotonergic cells respond to increase of CO2 to 9 % with an average 
increase in firing rate of 15.35 ± 8.37 % (n=11), significantly different from 
baseline  
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Fig. 28. Effect of change in concentration of CO2 in bath ACSF on firing of 
serotonergic neurons of wild-type (WT) and HTr1aRO mice (RO). The two panels 
show the time-course of experiments were 3-9% CO2 were repeatedly applied. 
Upper panel shows the degree in changes of firing during 3 or 9% CO2-ACSF 
perfusion in wild-type animals. Lower panel shows that in HTr1aRO mice no 
response is evoked by 3 or 9% CO2-ACSF perfusion. 
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 firing rate (P=0.001, Wilcoxon test). Conversely, following a decrease in CO2 to 3 
% they respond with an average decrease in firing rate of 13.01 ± 8.19 % (n=10), 
also significantly different from baseline (P=0.002, Wilcoxon test).  
In HTr1aRO mice, we found on average a 3.80 ± 10.61 % increase of firing 
following an increase of CO2 to 9 % in the bath (n=9) and an average decrease in 
firing rate of 3.99 ± 13.94 % following a decrease in CO2 to 3 % (n=5), each not 
different from baseline (P=0.300 and P=1.00, respectively, Wilcoxon test). 
Serotonergic cell responses to 9% application and 3% application were found to 
be significantly different, (P= 0.015 and P= 0.004 respectively, Mann-Whitney 
test) in HTr1aRO compared with wild-type mice values (Fig. 29). 
Therefore we can conclude that the sensitivity to CO2 change in extracellular 
space was absent in serotonergic neurons of HTr1aRO mice. 
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Fig. 29. Comparison between the fractional firing rate response to change in bath 
CO2 concentration in wild-type (WT) and HTr1aRO mice (RO) serotonergic 
neurons. Note the lack of response in HTr1aRO mice. Serotonergic cell responses 
to 9% application and 3% application were found to be significantly different in 
HTr1aRO compared with wild-type mice values (P= 0.015 and P= 0.004 
respectively, Mann-Whitney test). 
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 DISCUSSION 
 
The principal objective of the present work was the functional characterization of 
serotonergic neuron activity in the dorsal raphe of mutant mice bearing selective 
overexpression of 5-HT1A receptors in these cells.  
The interest for an in-depth knowledge of functional characteristics of 
serotonergic neurons in this mutant mouse resides in the fact that at early postnatal 
age these mice present severe autonomic disregulation that often produces life-
threatening cardiovascular crises. These, eventually result in newborn mice death, 
which presents striking similarities with sudden infant death syndrome (Audero et 
al., 2008). Equally interesting is the fact that in the surviving animals is present an 
altered behaviour of increased aggression (Gross C., personal communications). 
The research developed on three major intermingled lines, namely: i) assessment 
of distinctive parameters allowing the electrophysiological identification of 
serotonergic neurons when recording with advanced extracellular techniques 
(loose-seal cell-attached patch); ii) comparison of electrophysiological cell 
characteristics, firing pattern(s) and response to 5-HT1A receptor activation of 
serotonergic cells, in HTr1aRO compared to wild-type mice; iii) study of 
chemosensitivity of serotonergic cells in wild-type and HTr1aRO mutant mice. 
Our results show that autoinhibition is dramatically increased in serotonergic cells 
of dorsal raphe, despite the limited (two folds) increase in their 5-HT1A receptor-
mediated response, and that serotonergic neuron chemosensitivity, that is 
physiologically relevant to the respiratory alteration found in SIDS victims, is 
virtually absent in these mice. 
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Serotonergic neurons of 5-HT1ARO mice 
The major obstacle that hampers understanding of serotonergic cell functioning 
resides in the difficulties to electrophysiologically recognise serotonergic neurons 
which has often led to ambiguous results and contrasting interpretation.  
Namely, as serotonergic cells represent only a fraction of neurones localised in 
raphe nuclei (Steinbusch, 1981), their identification is required for investigating 
their response to various stimuli during electrophysiological experiments. 
Currently, electrophysiological identification of serotonergic neurons is based on 
their “characteristic” slow and regular pattern of firing and sensitivity to 5-HT1A 
receptor agonists (Vandermaelen & Aghajanian 1983).  
However, these criteria are not compelling, as demonstrated by the variety of 
firing patterns and electrophysiological properties revealed in studies where post-
hoc immunohistochemical identification of the recorded cell was applied.  
In addition, as immunohistochemical identification produces uncertain results (up 
to 40% false negative or doubtful labelling) it is not surprising that contrasting 
findings on electrophysiological, pharmacological and morphological 
characteristics of serotonergic cells have been published (Allers and Sharp, 2003; 
Kirby et al., 2003; Beck et al., 2004; Marinelli et al., 2004).  
In the present study, we identified serotonergic neurons in wild type and HTr1aRO 
mice combining a “visually guided selection” under IR microscopy (large neurons 
located in raphe midline) with the presence of an electrophysiological criterion 
(i.e. action potential duration and shape: HHW or action current UDI) that we 
developed and validated in C57bl/6 mice.  
The electrophysiological criterion defined neurons as serotonergic ones when the 
HHW of their action potential (or the UDI of their action current in loose-seal 
cell-attached patch) is greater 0.9 ms.  
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 In rare cases in which a further confirmation of neuron identity was considered 
useful, the addition of a pharmacological criterion (high responsiveness to 5-HT1A 
receptor activation, i.e. neuron responds to low concentrations of R-8-OH-DPAT: 
3-10 nM) allowed unambiguous identification of neurons. The combination of 
these criteria resulted well suited for discriminating serotonergic cells from other 
neurones in dorsal raphe, with a confidence greater than 99%, both in whole-cell 
and loose-seal cell-attached recordings. In addition, since one of the objectives of 
our research was to investigate the responsiveness of cells to 5-HT1A receptor 
activation, pharmacological additional criteria were almost always present in the 
protocol (e.g. responsiveness to α1 adrenoreceptor and/or 5-HT1A receptor 
agonists). 
The primary conclusion of this study is that serotonergic neurons of HTr1aRO 
mice differ from those of wild-type mice for a shorter action potential/current and 
their smaller size as assessed by measuring cell membrane total capacitance.  
Thus, the action current of HTr1aRO serotonergic cells resulted shorter than that of 
wild-type. This was apparently not due to an “acute” response to experimental 
conditions, as the waveform of action potential current was not modified e.g. by 
the effect of drugs applied. Rather, this modification is more likely due to 
developmental difference between the two mice, possibly linked to 5-HT1A 
receptor overexpression (see below).  
This was the only firing characteristic we found different. The intrinsic firing rate 
or the firing in the presence of phenylephrine were found similar as well as the 
response to phenylephrine activation, suggesting that apart from narrower action 
potential HTr1aRO serotonergic cells have an activity behaviour closely similar to 
that of wild type.  
Unfortunately, in most of whole-cell patch-clamp experiments it was impossible 
to reliably measure cell membrane potential at rest as well as cell input resistance 
and/or action potential shape because of spontaneous cell firing and/or 
modifications of these basic cell parameters introduced by recording 
conditions/protocols designed for the main investigation needs.  
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 In whole-cell patch-clamp, however, we found that cell capacitance of HTr1aRO 
serotonergic neurons was lower than that of wild type suggesting that the cell size 
and/or the dendritic arborization are decreased.  
We did not further investigate this issue. However, shorter action current and 
smaller neuron size could indicate a developmental modification in HTr1aRO 
serotonergic cells that is consistent with the alteration in raphe serotonergic 
neurons found SIDS victims. In fact, Paterson and Colleagues (2006) observed an 
increase in the population of serotonergic cells showing immature granular aspect 
and a decrease in serotonergic neurons with multipolar cell body. 
 
 
5-HT1A receptor expression levels and functional response to its activation 
We applied loose seal cell attached recording and whole-cell patch-clamp 
recording techniques to provide the first direct evidence of 5HT1A receptor 
functionality in identified serotonergic cells of HTr1aRO mice. 
We showed that the serotonergic raphe neurons of HTr1aRO mice, apart from the 
duration of action potential, have firing properties that are similar to those 
serotonergic neurons in wild type mice, and that the response to noradrenergic 
receptors activation, typical of waking condition, were also similar.  
Thus, we considered that functional behaviour of serotonergic cells was not 
significantly affected by the mutation and that we could compare the response to 
5-HT1A receptor activation on firing rate of serotonergic neurons in wild type and 
HTr1aRO mice.  
In this attempt we blocked the raphe network activity using a “cocktail” of 
antagonists for fast and slow synaptic transmission to study the effect of 5-HT1A 
receptor activation in isolation from the influence of principal external inputs (see 
in Adell et al., 2002).  
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 We have chosen to monitor serotonergic firing rate because it is an integrative 
parameter, which is informative about the behavioural activity of the neuron and, 
using the loose-seal cell-attached voltage clamp recording technique, it can be 
studied on intact cells with minimal perturbations.  
In HTr1aRO mice, we found that the 5-HT1A receptor-mediated inhibition of firing 
rate was roughly doubled compared to wild-type mice, which was consistent with 
an overexpression of functionally activable 5-HT1A receptors. However, taking 
into consideration that the estimated overexpression of 5-HT1A receptors 
approached ten times the normal density of these receptors in the raphe (Audero et 
al., 2008), this limited increase in functional response was unexpected. 
This inconsistency suggested the possibility that an adaptative mechanism 
prevented the firing rate to be changed over a given extent, masking the real 
response to 5-HT1A receptor activation. Therefore, we performed whole-cell 
experiments to compare the extent of activation of GIRK channels by 5-HT1A 
receptor stimulation in Htr1aRO and wild type mice. 
GIRK channels are directly activated by the βγ subunit of G-protein associated 
with 5-HT1A receptors and they are the principal mediators of serotonergic activity 
inhibition (Bayliss et al., 1997; Penington et al., 1993a, 1993b).  
Our results show that the maximal GIRK conductance activated by R-8-OH-
DPAT was similar in serotonergic cells of both mouse strains. Similar to firing 
rate inhibition, the concentration-response relationship of 5-HT1A receptor-
dependent activation of GIRK current in Htr1aRO mice was placed leftward to the 
curve in wild-type mice and EC50 values differed by a factor of two.  
These findings confirm that the functional response to 5-HT1A receptor activation 
does not linearly follow the number of receptor expressed, and suggest that the 
pool of 5-HT1A receptor-coupled G proteins and/or the availability of G protein 
coupled potassium channels are primary players in determining the extent of 
response.  
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5-HT1A functionality and autoinhibition in 5Htr1aRO mice 
From the same set of whole cell experiments we gain important information on 
the functionality of 5-HT1A receptors in these two mouse strains. We found that in 
basal conditions  a greater GIRK-like conductance is activated in serotonergic 
neurons of HTr1aRO mice compared to that present in wild-type serotonergic cells.  
This was verified also in more physiological conditions, i.e. using loose-seal cell-
attached patch recording from deeply-seated cells in the slice to avoid the 
excessive loss of endogenous serotonin surrounding perikarya and the regulatory 
mechanism associated with serotonin neurotransmission, normally present in vivo.  
Under these conditions the application of barium, a GIRK channel blocker, 
increased the firing rate “at rest” more in HTr1aRO mice (30 % circa) respect to 
wild type. In addition it was observed that the 5-HT1A receptor antagonist WAY 
100635 was able to increase firing rate to the same extent of barium (data not 
shown) suggesting that the basal GIRK channel conductance is activated by a pool 
of 5-HT1A receptors stimulated “at rest”. All together, these findings indicated that 
the basal 5HT1A receptor-mediated inhibition of serotonergic activity is more 
pronounced in  HTr1aRO mice respect to wild type. However, this seems in 
contrast with the fact that in loose seal cell attached experiments we were unable 
to detect a significantly lower “intrinsic” firing rate, or a lower firing rate in 
phenylephrine, in HTr1aRO serotonergic cells compared to those present in wild 
type mice.  
We interpreted this failure with the higher variability in the extent of 
autoinhibition present in the in vitro condition, where the content of serotonin in 
slices is greatly reduced compared to physiological level and, in addition, depends 
on the depth of serotonergic cell location within the preparation (Mlinar et al., 
2005, Liu et al., 2005). Indeed, when endogenous synthesis of serotonin was 
restored by supplementation of L-tryptophan in ACSF, the 5-HT1A receptor-
mediated inhibition of serotonergic firing rate was about nine times greater than 
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 the one in wild type, thus correlating well with the difference in 5-HT1A receptor 
density in raphe serotonergic cells of these two mice. 
On the other hand, the discrepancy between the effect of synthetic 5-HT1A 
receptor agonists (R-8-OH-DPAT, 5-CT) and endogenous serotonin was striking 
and difficult to explain.  
The effect of L-tryptophan can be influenced by several factors regulating the 
synthesis and turnover of serotonin or the processes of release and uptake (Adell 
et al., 2002); therefore we hypothesised that the mutants could have other factors 
influencing the firing response to L-tryptophan/newly synthesised serotonin. For 
instance, HTr1aRO mice are heterozygous for the gene coding for the membrane 
transporter (see Experimental procedures) and therefore the increase in response 
could have been caused by a partial decrease in serotonin uptake. Should re-
uptake mechanisms be altered this would not affect the response to exogenous, 
synthetic, agonists for 5-HT1A receptors, but would possibly affect the response to 
endogenously released serotonin. Our experiments in which we tested the 
sensitivity to L-tryptophan in doxycycline-treated HTr1aRO mice (in which the 
5-HT1A receptor overexpression was blocked) demonstrate that the increase in 
response to L-tryptophan is not linked to a reduced expression of membrane 
serotonin transporter.  
We are therefore confident that L-tryptophan-induced firing rate inhibition was 
strictly dependent on 5-HT1A receptor density on serotonergic neurons. Moreover, 
at the end of some experiments the perfusion of barium recovered the firing rate to 
control values, confirming the involvement of GIRK channels in mediating L-
tryptophan response. Finally, the selective 5-HT1A receptor antagonist 
WAY100635 (Corradetti et al., 1996) was applied with the same result, as 
previously shown (Audero et al., 2008), confirming that inhibition of neuron 
firing rate was via activation of 5-HT1A receptors during L-tryptophan 
superfusion. 
In conclusion, although we do not have a direct explanation for the discrepancy 
between the effects of synthetic 5-HT1A receptor agonists and endogenous 
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 serotonin, it appears evident that in conditions approaching the physiological state 
in vivo, where the supply of L-tryptophan is not restricted and serotonin is freely 
accessing the overexpressed 5-HT1A receptors, autoinhibition of serotonergic cells 
is extremely enhanced in HTr1aRO mice, compared to controls. 
 
 
CO2/pH chemosensivity of serotonergic neurons in Htr1aRO mice 
Once we had defined electrophysiological parameters distinctive of serotonergic 
cells with an unprecedented accuracy we used this knowledge for the 
identification of serotonergic neurones during recording from Htr1aRO mice, 
which has been proposed as animal model of Sudden Infant Death Syndrome, 
SIDS (Audero et al., 2008). This allowed us to begin our study on how an altered 
autoinhibitory feedback could affect autonomic functions to a life-threatening 
level as in SIDS. 
SIDS is a combination of genetic, metabolic and environmental factors that 
culminate in the death of an infant. In Italy, SIDS is still one major cause of infant 
deaths (0.5% of live births). Several studies suggested that autonomic control and 
arousal responsiveness are altered in these infants and implicated in SIDS 
causation (Moon et al., 2007). It has been proposed that the mechanisms leading 
to SIDS represent a failure in the neural integration of the cardiovascular and 
respiratory systems, with a concomitant failure to arouse from sleep (Harper et al., 
2000; Horne et al., 2004). An increasing number of studies indicates that genetic, 
developmental, or functional alterations of the serotonergic system may contribute 
to SIDS (Okado et al., 2002; Sawaguchi et al., 2003; Paterson et al., 2007; Rand et 
al., 2007; Hodges et al., 2008; Morley et al., 2008; Thach, 2008; Duncan et al., 
2010). This is not surprising given the modulatory actions of serotonin on many 
physiological functions (e.g. arousal, sleep, cardiorespiratory, and 
thermoregulatory functions) that resulted anomalous or impaired in newborns that 
succumbed to SIDS. Notably, serotonergic cells respond to modification in 
extracellular CO2/pH with changes in firing frequency, thereby modulating 
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 cardiorespiratory centres and participating to homeostatic reflexes (Washburn et 
al., 2002; Severson et al., 2003; Richerson, 2004; Dias el al., 2007; Mulkey et al., 
2007; Guyenet et al., 2008; Li et al., 2008). In this context, our hypothesis is that 
increased autoinhibition dampens/blocks serotonin system response to chemical 
stimuli such as hypoxia, hypercapnia or acidosis, which occur during sleep in 
infants and normally elicit respiratory responses, arousal and avoidance reflexes.  
We tested this hypothesis in Htr1aRO mice in which excessive serotonergic 
autoinhibition had been already associated with spontaneous bradycardic and 
hypothermic crises that occurred during a limited developmental period and 
frequently progressed to death.  
In the present thesis I have shown that CO2 chemosensitivity was absent in 
HTr1aRO mice providing a further analogy with human pathology and 
strengthening the notion that the autonomic disregulation present in these mice 
could be used for elucidating functional mechanisms of SIDS-like autonomic 
deficits.  
We found significant differences between the response to CO2 of wild type and 
HTr1aRO mice. However, the chemosensitive response in wild-type mice was 
smaller than that described by other Authors both in mice and rats (Richerson 
1995; Wang et al., 2002; Severson et al., 2003).  
A reduced chemosensitivity is unlikely to be caused by application of CO2 
concentrations not sufficient to change pH in our conditions, as we always 
controlled the pH of our solutions.  
Furthermore, experiments were performed in the presence of synaptic blockers to 
isolate the neuronal intrinsic properties, and therefore we do not expect that local 
feed-back regulation of serotonergic cell firing by surrounding terminals and 
neurons would dampen the response to CO2. We made additional tests in the 
absence of phenylephrine to exclude that α1-adrenoceptor activation could mask 
the changes in neuron firing rate produced by CO2, but we did not find a greater 
increase in responses to CO2 challenge in this condition. It must be noted that we 
recorded from a selected population of dorsal raphe serotonergic cells that may 
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 have smaller responses to CO2 compared to those observed in medullary raphe 
nuclei that are the most studied as chemoreceptors. 
Although we observed a small increase of firing rate in dorsal raphe, it may still 
be significant for respiratory chemoreceptors, since there are many ways for a 
small response of a neuron to be amplified downstream and cause a large increase 
in breathing (Richerson et al, 2005). 
Finally, we cannot discard the possibility that the wild-type animals, we used for 
their genetic background common with that of HTr1aRO mutants, have smaller 
CO2 sensitivity than non transgenic mice like C57bl/6. Although we did not 
directly test this possibility, yet, we think that great differences based on genetic 
background are unlikely to be present in wild-type mice, since they retain a 
response to CO2 and grow perfectly healthy. 
In conclusion, the suppression of this homeostatic property seems linked to 
increased serotonergic autoinhibition in HTr1aRO mice and the importance of this 
regulatory mechanism may be relevant to the SIDS phenotype of these animals. 
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 CONCLUSIONS AND PERSPECTIVES 
 
The present study shows that 5-HT1A receptor overexpression in serotonergic cells 
of dorsal raphe nuclei produces limited changes in the functional response to 
direct 5-HT1A receptor activation, but greatly enhances the response to activation 
of the same receptors mediated by endogenous serotonin. Thus, autoinhibition is 
enormously increased in these cells. Further studies are needed to fully elucidate 
the mechanisms by which overexpression of 5-HT1A receptors leads to excessive 
autoinhibition in HTr1aRO mice.  
The second important finding of the present work is that serotonergic cells with 5-
HT1A receptors overexpression lost their sensitivity to changes in extracellular 
CO2 concentration. This provides a possible explanation for the SIDS-like events 
in these mice.  
It would be of interest for future studies to investigate if this deficit extends to 
other raphe nuclei and if it is important in vivo in experimental conditions of 
hypercapnia. 
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